TAR	B-DNA
-independent	O
transactivation	O
by	O
Tat	B-protein
in	O
cells	O
derived	O
from	O
the	O
CNS	O
:	O
a	O
novel	O
mechanism	O
of	O
HIV-1	O
gene	O
regulation	O
.	O

The	O
Tat	B-protein
protein	I-protein
of	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
is	O
essential	O
for	O
productive	O
infection	O
and	O
is	O
a	O
potential	O
target	O
for	O
antiviral	O
therapy	O
.	O

Tat	B-protein
,	O
a	O
potent	O
activator	O
of	O
HIV-1	O
gene	O
expression	O
,	O
serves	O
to	O
greatly	O
increase	O
the	O
rate	O
of	O
transcription	O
directed	O
by	O
the	O
viral	B-DNA
promoter	I-DNA
.	O

This	O
induction	O
,	O
which	O
seems	O
to	O
be	O
an	O
important	O
component	O
in	O
the	O
progression	O
of	O
acquired	O
immune	O
deficiency	O
syndrome	O
(	O
AIDS	O
)	O
,	O
may	O
be	O
due	O
to	O
increased	O
transcriptional	O
initiation	O
,	O
increased	O
transcriptional	O
elongation	O
,	O
or	O
a	O
combination	O
of	O
these	O
processes	O
.	O

Much	O
attention	O
has	O
been	O
focused	O
on	O
the	O
interaction	O
of	O
Tat	B-protein
with	O
a	O
specific	O
RNA	B-RNA
target	I-RNA
termed	O
TAR	B-RNA
(	O
transactivation	B-RNA
responsive	I-RNA
)	O
which	O
is	O
present	O
in	O
the	O
leader	O
sequence	O
of	O
all	O
HIV-1	B-RNA
mRNAs	I-RNA
.	O

This	O
interaction	O
is	O
believed	O
to	O
be	O
an	O
important	O
component	O
of	O
the	O
mechanism	O
of	O
transactivation	O
.	O

In	O
this	O
report	O
we	O
demonstrate	O
that	O
in	O
certain	O
CNS-derived	B-cell_line
cells	I-cell_line
Tat	B-protein
is	O
capable	O
of	O
activating	O
HIV-1	O
through	O
a	O
TAR	B-DNA
-independent	O
pathway	O
.	O

A	O
Tat-responsive	B-DNA
element	I-DNA
is	O
found	O
upstream	O
within	O
the	O
viral	B-DNA
promoter	I-DNA
that	O
in	O
glial-derived	B-cell_line
cell	I-cell_line
lines	I-cell_line
allows	O
transactivation	O
in	O
the	O
absence	O
of	O
TAR	B-RNA
.	O

Deletion	O
mapping	O
and	O
hybrid	B-DNA
promoter	I-DNA
constructs	I-DNA
demonstrate	O
that	O
the	O
newly	O
identified	O
Tat-responsive	B-DNA
element	I-DNA
corresponds	O
to	O
a	O
sequence	O
within	O
the	O
viral	B-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
(	O
LTR	B-DNA
)	O
previously	O
identified	O
as	O
the	O
HIV-1	B-DNA
enhancer	I-DNA
,	O
or	O
NF-kappa	B-DNA
B	I-DNA
domain	I-DNA
.	O

DNA	O
band-shift	O
analysis	O
reveals	O
NF-kappa	B-protein
B	I-protein
binding	O
activity	O
in	O
glial	O
cells	O
that	O
differs	O
from	O
that	O
present	O
in	O
T	B-cell_type
lymphoid	I-cell_type
cells	I-cell_type
.	O

Further	O
,	O
we	O
observe	O
that	O
TAR-deleted	B-DNA
mutants	I-DNA
of	O
HIV-1	O
demonstrate	O
normal	O
late	O
gene	O
expression	O
in	O
glial	B-cell_type
cells	I-cell_type
as	O
evidenced	O
by	O
syncytia	O
formation	O
and	O
production	O
of	O
viral	B-protein
p24	I-protein
antigen	I-protein
.	O

(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

The	NULL
EMBO	NULL
Journal	NULL
vol.11	NULL
no.9	NULL
pp.3395	NULL
-	NULL
3403	NULL
,	NULL
1992	NULL
TAR-independent	NULL
transactivation	NULL
by	NULL
Tat	NULL
in	NULL
cells	NULL
derived	NULL
from	NULL
the	NULL
CNS	NULL
:	NULL
a	NULL
novel	NULL
mechanism	NULL
of	NULL
HIV-1	NULL
gene	NULL
regulation	NULL
J.Paul	NULL
Taylor	NULL
,	NULL
Roger	NULL
Pomerantz	NULL
'	NULL
,	NULL
Omar	NULL
Bagasra	NULL
'	NULL
,	NULL
Mashiul	NULL
Chowdhury	NULL
,	NULL
Jay	NULL
Rappaport®	NULL
,	NULL
Kamel	NULL
Khalili®	NULL
and	NULL
Shohreh	NULL
Amini	NULL
Department	NULL
of	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Molecular	NULL
Neurovirology	NULL
Section	NULL
,	NULL
Jefferson	NULL
Institute	NULL
of	NULL
Molecular	NULL
Medicine	NULL
,	NULL
'Department	NULL
of	NULL
Medicine	NULL
,	NULL
Division	NULL
of	NULL
Infectious	NULL
Disease	NULL
,	NULL
Thomas	NULL
Jefferson	NULL
University	NULL
,	NULL
Philadelphia	NULL
,	NULL
PA	NULL
19107	NULL
and	NULL
Laboratory	NULL
of	NULL
Oral	NULL
Medicine	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Dental	NULL
Research	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
and	NULL
Division	NULL
of	NULL
Renal	NULL
Diseases	NULL
and	NULL
Hypertension	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
The	NULL
George	NULL
Washington	NULL
University	NULL
,	NULL
Washington	NULL
,	NULL
CD	NULL
20037	NULL
,	NULL
USA	NULL
*Corresponding	NULL
author	NULL
Communicated	NULL
by	NULL
R.Perry	NULL
The	NULL
Tat	NULL
protein	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
is	NULL
essential	NULL
for	NULL
productive	NULL
infection	NULL
and	NULL
is	NULL
a	NULL
potential	NULL
target	NULL
for	NULL
antiviral	NULL
therapy	NULL
.	NULL

Tat	NULL
,	NULL
a	NULL
potent	NULL
activator	NULL
of	NULL
HIV-1	NULL
gene	NULL
expression	NULL
,	NULL
serves	NULL
to	NULL
greatly	NULL
increase	NULL
the	NULL
rate	NULL
of	NULL
transcription	NULL
directed	NULL
by	NULL
the	NULL
viral	NULL
promoter	NULL
.	NULL

This	NULL
induction	NULL
,	NULL
which	NULL
seems	NULL
to	NULL
be	NULL
an	NULL
important	NULL
component	NULL
in	NULL
the	NULL
progression	NULL
of	NULL
acquired	NULL
immune	NULL
deficiency	NULL
syndrome	NULL
(	NULL
AIDS	NULL
)	NULL
,	NULL
may	NULL
be	NULL
due	NULL
to	NULL
increased	NULL
transcriptional	NULL
initiation	NULL
,	NULL
increased	NULL
transcriptional	NULL
elongation	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
these	NULL
processes	NULL
.	NULL

Much	NULL
attention	NULL
has	NULL
been	NULL
focused	NULL
on	NULL
the	NULL
interaction	NULL
of	NULL
Tat	NULL
with	NULL
a	NULL
specific	NULL
RNA	NULL
target	NULL
termed	NULL
TAR	NULL
(	NULL
trans-activation	NULL
responsive	NULL
)	NULL
which	NULL
is	NULL
present	NULL
in	NULL
the	NULL
leader	NULL
sequence	NULL
of	NULL
all	NULL
HIV-1	NULL
mRNAs	NULL
.	NULL

This	NULL
interaction	NULL
is	NULL
believed	NULL
to	NULL
be	NULL
an	NULL
important	NULL
component	NULL
of	NULL
the	NULL
mechanism	NULL
of	NULL
transactivation	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
demonstrate	NULL
that	NULL
in	NULL
certain	NULL
CNS-derived	NULL
cells	NULL
Tat	NULL
is	NULL
capable	NULL
of	NULL
activating	NULL
HIV-1	NULL
through	NULL
a	NULL
TAR-independent	NULL
pathway	NULL
.	NULL

A	NULL
Tat-responsive	NULL
element	NULL
is	NULL
found	NULL
upstream	NULL
within	NULL
the	NULL
viral	NULL
promoter	NULL
that	NULL
in	NULL
glial-derived	NULL
cell	NULL
lines	NULL
allows	NULL
transactivation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TAR	NULL
.	NULL

Deletion	NULL
mapping	NULL
and	NULL
hybrid	NULL
promoter	NULL
constructs	NULL
demonstrate	NULL
that	NULL
the	NULL
newly	NULL
identified	NULL
Tat-responsive	NULL
element	NULL
corresponds	NULL
to	NULL
a	NULL
sequence	NULL
within	NULL
the	NULL
viral	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
previously	NULL
identified	NULL
as	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
,	NULL
or	NULL
NF-xB	NULL
domain	NULL
.	NULL

DNA	NULL
band-shift	NULL
analysis	NULL
reveals	NULL
NF-xB	NULL
binding	NULL
activity	NULL
in	NULL
glial	NULL
cells	NULL
that	NULL
differs	NULL
from	NULL
that	NULL
present	NULL
in	NULL
T	NULL
lymphoid	NULL
cells	NULL
.	NULL

Further	NULL
,	NULL
we	NULL
observe	NULL
that	NULL
TAR-deleted	NULL
mutants	NULL
of	NULL
HIV-1	NULL
demonstrate	NULL
normal	NULL
late	NULL
gene	NULL
expression	NULL
in	NULL
glial	NULL
cells	NULL
as	NULL
evidenced	NULL
by	NULL
syncytia	NULL
formation	NULL
and	NULL
production	NULL
of	NULL
viral	NULL
p24	NULL
antigen	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
upstream	NULL
Tat-responsive	NULL
element	NULL
is	NULL
sufficiently	NULL
active	NULL
to	NULL
support	NULL
viral	NULL
replication	NULL
and	NULL
indicate	NULL
that	NULL
an	NULL
alternative	NULL
regulatory	NULL
circuit	NULL
influencing	NULL
HIV-1	NULL
gene	NULL
expression	NULL
is	NULL
operational	NULL
within	NULL
some	NULL
cells	NULL
.	NULL

Key	NULL
words	NULL
:	NULL
HIV-1/TAR	NULL
element/Tat	NULL
protein	NULL
©	NULL
Oxford	NULL
University	NULL
Press	NULL
Introduction	NULL
AIDS	NULL
and	NULL
related	NULL
conditions	NULL
caused	NULL
by	NULL
infection	NULL
with	NULL
HIV	NULL
are	NULL
frequently	NULL
associated	NULL
with	NULL
multiple	NULL
disorders	NULL
of	NULL
the	NULL
central	NULL
nervous	NULL
system	NULL
(	NULL
CNS	NULL
)	NULL
(	NULL
Price	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
,	NULL
1990	NULL
;	NULL
Rosenblum	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

At	NULL
least	NULL
60	NULL
%	NULL
of	NULL
AIDS	NULL
patients	NULL
develop	NULL
symptoms	NULL
of	NULL
neurologic	NULL
disease	NULL
and	NULL
90	NULL
%	NULL
demonstrate	NULL
neuropathologic	NULL
abnormalities	NULL
at	NULL
autopsy	NULL
(	NULL
Navia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Lechtenberg	NULL
and	NULL
Sher	NULL
,	NULL
1988	NULL
)	NULL
.	NULL

In	NULL
some	NULL
cases	NULL
neurologic	NULL
complications	NULL
dominate	NULL
the	NULL
clinical	NULL
course	NULL
or	NULL
are	NULL
the	NULL
only	NULL
manifestation	NULL
of	NULL
AIDS	NULL
(	NULL
Navia	NULL
and	NULL
Price	NULL
,	NULL
1987	NULL
)	NULL
.	NULL

Debilitating	NULL
dementia	NULL
,	NULL
encephalopathy	NULL
and	NULL
opportunistic	NULL
infections	NULL
are	NULL
the	NULL
abnormalities	NULL
most	NULL
commonly	NULL
observed	NULL
(	NULL
Epstein	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Price	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
,	NULL
1990	NULL
;	NULL
Gabuzda	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
HIV-1	NULL
in	NULL
the	NULL
brain	NULL
and	NULL
cerebrospinal	NULL
fluid	NULL
(	NULL
CSF	NULL
)	NULL
of	NULL
AIDS	NULL
patients	NULL
and	NULL
a	NULL
strong	NULL
correlation	NULL
between	NULL
the	NULL
level	NULL
of	NULL
HIV-1	NULL
expression	NULL
and	NULL
clinical	NULL
severity	NULL
strongly	NULL
suggest	NULL
a	NULL
direct	NULL
role	NULL
for	NULL
HIV-1	NULL
in	NULL
some	NULL
of	NULL
the	NULL
neurological	NULL
complications	NULL
found	NULL
in	NULL
infected	NULL
individuals	NULL
(	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Levy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Gyorkey	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Koenig	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Giulian	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
precise	NULL
mechanism	NULL
of	NULL
pathogenesis	NULL
within	NULL
the	NULL
CNS	NULL
is	NULL
not	NULL
yet	NULL
clear	NULL
.	NULL

A	NULL
direct	NULL
cytopathic	NULL
effect	NULL
in	NULL
infected	NULL
cells	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
some	NULL
HIV	NULL
-induced	NULL
CNS	NULL
disease	NULL
;	NULL
it	NULL
has	NULL
also	NULL
been	NULL
suggested	NULL
that	NULL
toxic	NULL
substances	NULL
released	NULL
from	NULL
infected	NULL
cells	NULL
may	NULL
be	NULL
deleterious	NULL
to	NULL
CNS	NULL
function	NULL
(	NULL
Giulian	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Within	NULL
the	NULL
CNS	NULL
,	NULL
HIV-1	NULL
infection	NULL
has	NULL
been	NULL
observed	NULL
predominantly	NULL
in	NULL
microglia	NULL
,	NULL
but	NULL
infection	NULL
is	NULL
also	NULL
observed	NULL
in	NULL
oligodendroglia	NULL
,	NULL
astroglia	NULL
and	NULL
neurons	NULL
(	NULL
Koenig	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Wiley	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Gyorkey	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Ward	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Michaels	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Price	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Rhodes	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

Further	NULL
,	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
many	NULL
astrocytic	NULL
cell	NULL
lines	NULL
are	NULL
permissive	NULL
to	NULL
HIV-1	NULL
infection	NULL
in	NULL
vitro	NULL
(	NULL
Cheng-Mayer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Chiodi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Dewhurst	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

Some	NULL
studies	NULL
report	NULL
low	NULL
levels	NULL
or	NULL
fail	NULL
to	NULL
detect	NULL
virus	NULL
in	NULL
astrocytes	NULL
.	NULL

These	NULL
observations	NULL
may	NULL
reflect	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
lytic	NULL
cycle	NULL
in	NULL
astrocytes	NULL
.	NULL

Evidence	NULL
suggests	NULL
that	NULL
HIV-1	NULL
infects	NULL
astrocytes	NULL
latently	NULL
,	NULL
making	NULL
the	NULL
virus	NULL
difficult	NULL
to	NULL
detect	NULL
,	NULL
yet	NULL
expression	NULL
is	NULL
reactivated	NULL
by	NULL
specific	NULL
cytokines	NULL
or	NULL
contact	NULL
with	NULL
lymphoid	NULL
or	NULL
monocytoid	NULL
cells	NULL
resulting	NULL
in	NULL
a	NULL
cytopathic	NULL
effect	NULL
and	NULL
virus	NULL
transmission	NULL
to	NULL
other	NULL
permissive	NULL
cells	NULL
(	NULL
Chiodi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Dewhurst	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Tornatore	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

This	NULL
latent	NULL
infection	NULL
may	NULL
serve	NULL
as	NULL
a	NULL
large	NULL
viral	NULL
reservoir	NULL
and	NULL
,	NULL
in	NULL
addition	NULL
,	NULL
contribute	NULL
to	NULL
significant	NULL
CNS	NULL
pathology	NULL
upon	NULL
reactivation	NULL
(	NULL
Pomerantz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Productive	NULL
infection	NULL
by	NULL
HIV-1	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
regulatory	NULL
protein	NULL
Tat	NULL
(	NULL
Dayton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Fisher	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
,	NULL
a	NULL
potent	NULL
activator	NULL
of	NULL
HIV-1	NULL
gene	NULL
expression	NULL
(	NULL
Arya	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Sodroski	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
)	NULL
.	NULL

Since	NULL
production	NULL
of	NULL
Tat	NULL
is	NULL
also	NULL
augmented	NULL
upon	NULL
activation	NULL
,	NULL
this	NULL
viral	NULL
protein	NULL
serves	NULL
to	NULL
establish	NULL
a	NULL
strong	NULL
positive	NULL
feedback	NULL
loop	NULL
that	NULL
results	NULL
in	NULL
a	NULL
massive	NULL
induction	NULL
of	NULL
HIV-1	NULL
gene	NULL
expression	NULL
and	NULL
,	NULL
3395	NULL
J.P.Taylor	NULL
et	NULL
al	NULL
.	NULL

consequently	NULL
,	NULL
further	NULL
propagation	NULL
of	NULL
the	NULL
infection	NULL
(	NULL
Cullen	NULL
and	NULL
Greene	NULL
,	NULL
1989	NULL
;	NULL
Cullen	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

Tat	NULL
belongs	NULL
to	NULL
an	NULL
emerging	NULL
class	NULL
of	NULL
regulatory	NULL
proteins	NULL
that	NULL
exert	NULL
their	NULL
function	NULL
after	NULL
binding	NULL
to	NULL
a	NULL
specific	NULL
RNA	NULL
target	NULL
(	NULL
Lazinski	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Tat	NULL
binds	NULL
to	NULL
a	NULL
specific	NULL
RNA	NULL
structure	NULL
,	NULL
termed	NULL
the	NULL
TAR	NULL
element	NULL
,	NULL
found	NULL
at	NULL
the	NULL
5'-end	NULL
of	NULL
all	NULL
HIV-1	NULL
mRNAs	NULL
(	NULL
Dingwall	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Muller	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Roy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Calnan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991a	NULL
,	NULL
b	NULL
)	NULL
.	NULL

It	NULL
appears	NULL
that	NULL
interaction	NULL
of	NULL
this	NULL
regulatory	NULL
protein	NULL
with	NULL
this	NULL
specific	NULL
RNA	NULL
target	NULL
is	NULL
an	NULL
important	NULL
component	NULL
of	NULL
the	NULL
activation	NULL
mechanism	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Feng	NULL
and	NULL
Holland	NULL
,	NULL
1988	NULL
;	NULL
Berkhout	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Calnan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991a	NULL
,	NULL
b	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
evidence	NULL
suggests	NULL
that	NULL
upstream	NULL
regulatory	NULL
elements	NULL
within	NULL
the	NULL
viral	NULL
promoter	NULL
are	NULL
required	NULL
to	NULL
mediate	NULL
Tat	NULL
transactivation	NULL
(	NULL
Berkhout	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Southgate	NULL
and	NULL
Green	NULL
,	NULL
1991	NULL
;	NULL
Kamine	NULL
ert	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

We	NULL
undertook	NULL
a	NULL
study	NULL
of	NULL
the	NULL
mechanism	NULL
of	NULL
activation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
by	NULL
the	NULL
Tat	NULL
protein	NULL
.	NULL

Our	NULL
initial	NULL
findings	NULL
demonstrated	NULL
that	NULL
within	NULL
cells	NULL
derived	NULL
from	NULL
the	NULL
CNS	NULL
,	NULL
Tat	NULL
transactivation	NULL
occurs	NULL
independent	NULL
of	NULL
the	NULL
TAR	NULL
element	NULL
,	NULL
suggesting	NULL
that	NULL
an	NULL
alternative	NULL
mechanism	NULL
of	NULL
transcriptional	NULL
control	NULL
is	NULL
functional	NULL
within	NULL
these	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
here	NULL
(	NULL
i	NULL
)	NULL
demonstrate	NULL
TAR-independent	NULL
transactivation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
by	NULL
the	NULL
Tat	NULL
protein	NULL
in	NULL
a	NULL
cell-type	NULL
specific	NULL
manner	NULL
,	NULL
(	NULL
ii	NULL
)	NULL
show	NULL
detail	NULL
mapping	NULL
experiments	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
that	NULL
identify	NULL
the	NULL
promoter	NULL
element	NULL
responsible	NULL
for	NULL
mediating	NULL
Tat	NULL
responsiveness	NULL
,	NULL
(	NULL
iii	NULL
)	NULL
demonstrate	NULL
the	NULL
differences	NULL
between	NULL
glial	NULL
cells	NULL
and	NULL
T	NULL
cells	NULL
in	NULL
binding	NULL
activity	NULL
to	NULL
this	NULL
Tat-responsive	NULL
element	NULL
,	NULL
and	NULL
(	NULL
iv	NULL
)	NULL
demonstrate	NULL
that	NULL
this	NULL
novel	NULL
mechanism	NULL
of	NULL
transcriptional	NULL
activation	NULL
by	NULL
Tat	NULL
is	NULL
sufficient	NULL
to	NULL
support	NULL
normal	NULL
HIV-1	NULL
gene	NULL
expression	NULL
.	NULL

Results	NULL
In	NULL
glial-derived	NULL
cell	NULL
lines	NULL
Tat	NULL
transactivates	NULL
the	NULL
LTR	NULL
in	NULL
a	NULL
TAR-independent	NULL
fashion	NULL
The	NULL
consequence	NULL
of	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
by	NULL
Tat	NULL
is	NULL
an	NULL
enhanced	NULL
rate	NULL
of	NULL
transcription	NULL
.	NULL

This	NULL
induction	NULL
may	NULL
result	NULL
from	NULL
an	NULL
increased	NULL
rate	NULL
of	NULL
transcription	NULL
initiation	NULL
,	NULL
more	NULL
efficient	NULL
elongation	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
these	NULL
mechanisms	NULL
(	NULL
Laspia	NULL
ert	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
,	NULL
1990	NULL
;	NULL
Feinberg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

This	NULL
transactivation	NULL
leads	NULL
to	NULL
greatly	NULL
increased	NULL
levels	NULL
of	NULL
LTR-directed	NULL
mRNAs	NULL
(	NULL
Muesing	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
examine	NULL
this	NULL
phenomenon	NULL
within	NULL
glial	NULL
cells	NULL
,	NULL
a	NULL
plasmid	NULL
expressing	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
under	NULL
direction	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
was	NULL
cotransfected	NULL
with	NULL
a	NULL
Tat	NULL
expression	NULL
plasmid	NULL
into	NULL
the	NULL
cell	NULL
lines	NULL
U87MG	NULL
,	NULL
U138MG	NULL
(	NULL
both	NULL
derived	NULL
from	NULL
human	NULL
glioblastomas	NULL
)	NULL
and	NULL
C6	NULL
(	NULL
derived	NULL
from	NULL
a	NULL
rat	NULL
glioblastoma	NULL
)	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
Tat	NULL
results	NULL
in	NULL
the	NULL
transactivation	NULL
of	NULL
LTR-directed	NULL
transcription	NULL
comparable	NULL
to	NULL
that	NULL
seen	NULL
in	NULL
cell	NULL
lines	NULL
of	NULL
non-CNS	NULL
origin	NULL
,	NULL
i.e	NULL
.	NULL

H9	NULL
,	NULL
HeLa	NULL
and	NULL
COS	NULL
(	NULL
Figure	NULL
1A	NULL
-F	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
dependence	NULL
of	NULL
Tat	NULL
activity	NULL
on	NULL
the	NULL
TAR	NULL
element	NULL
,	NULL
the	NULL
LTR-CAT	NULL
construct	NULL
was	NULL
modified	NULL
so	NULL
that	NULL
sequences	NULL
encoding	NULL
TAR	NULL
were	NULL
deleted	NULL
.	NULL

The	NULL
minimal	NULL
functional	NULL
TAR	NULL
element	NULL
is	NULL
encoded	NULL
by	NULL
nucleotides	NULL
+19	NULL
to	NULL
+42	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

The	NULL
TAR-deleted	NULL
LTR	NULL
was	NULL
created	NULL
by	NULL
removal	NULL
of	NULL
nucleotides	NULL
downstream	NULL
of	NULL
+24	NULL
by	NULL
restriction	NULL
digestion	NULL
(	NULL
ATAR	NULL
constructs	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
removal	NULL
of	NULL
the	NULL
TAR	NULL
sequence	NULL
from	NULL
the	NULL
LTR	NULL
abolishes	NULL
Tat	NULL
responsiveness	NULL
in	NULL
cells	NULL
of	NULL
non-glial	NULL
origin	NULL
(	NULL
Hauber	NULL
and	NULL
Cullen	NULL
,	NULL
1988	NULL
;	NULL
Okamoto	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
we	NULL
observe	NULL
that	NULL
Tat	NULL
is	NULL
unable	NULL
to	NULL
activate	NULL
expression	NULL
of	NULL
the	NULL
TAR-deleted	NULL
LTR	NULL
in	NULL
either	NULL
an	NULL
unstimulated	NULL
lymphoid	NULL
3396	NULL
cell	NULL
line	NULL
(	NULL
H9	NULL
)	NULL
or	NULL
non-lymphoid	NULL
cell	NULL
lines	NULL
(	NULL
COS	NULL
and	NULL
HeLa	NULL
)	NULL
(	NULL
Figure	NULL
1D-F	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
glial-derived	NULL
cell	NULL
lines	NULL
,	NULL
significant	NULL
transactivation	NULL
is	NULL
still	NULL
detected	NULL
(	NULL
Figure	NULL
1A	NULL
-C	NULL
)	NULL
.	NULL

Quantitation	NULL
of	NULL
the	NULL
CAT	NULL
activity	NULL
reveals	NULL
cell-type	NULL
specific	NULL
differences	NULL
in	NULL
basal	NULL
transcription	NULL
level	NULL
,	NULL
but	NULL
demonstrates	NULL
that	NULL
the	NULL
TAR	NULL
deletion	NULL
itself	NULL
does	NULL
not	NULL
influence	NULL
basal	NULL
transcription	NULL
(	NULL
Figure	NULL
1A'-F	NULL
'	NULL
)	NULL
.	NULL

The	NULL
TAR	NULL
deletion	NULL
,	NULL
therefore	NULL
,	NULL
only	NULL
influences	NULL
Tat	NULL
responsiveness	NULL
.	NULL

Cotransfection	NULL
experiments	NULL
performed	NULL
with	NULL
Tat	NULL
expressed	NULL
from	NULL
a	NULL
variety	NULL
of	NULL
promoters	NULL
(	NULL
human	NULL
B-actin	NULL
,	NULL
cytomegalovirus	NULL
immediate	NULL
early	NULL
and	NULL
SV40	NULL
late	NULL
promoters	NULL
)	NULL
yielded	NULL
consistent	NULL
results	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

A	NULL
nuclease	NULL
S1	NULL
protection	NULL
assay	NULL
was	NULL
used	NULL
to	NULL
quantitate	NULL
LTR-directed	NULL
mRNA	NULL
from	NULL
transfected	NULL
cells	NULL
.	NULL

Densitometric	NULL
analysis	NULL
indicates	NULL
that	NULL
with	NULL
Tat	NULL
transactivation	NULL
the	NULL
quantity	NULL
of	NULL
transcripts	NULL
produced	NULL
from	NULL
the	NULL
TAR-deleted	NULL
LTR	NULL
is	NULL
~30	NULL
%	NULL
of	NULL
that	NULL
seen	NULL
with	NULL
the	NULL
intact	NULL
LTR	NULL
(	NULL
Figure	NULL
2A	NULL
)	NULL
.	NULL

These	NULL
results	NULL
confirm	NULL
that	NULL
the	NULL
observed	NULL
CAT	NULL
activity	NULL
reflects	NULL
increases	NULL
in	NULL
steady-state	NULL
levels	NULL
of	NULL
mRNA	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
equivalent	NULL
amounts	NULL
of	NULL
the	NULL
same	NULL
RNA	NULL
with	NULL
a	NULL
probe	NULL
for	NULL
B-actin	NULL
serves	NULL
as	NULL
a	NULL
control	NULL
for	NULL
RNA	NULL
integrity	NULL
and	NULL
concentration	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
.	NULL

Primer	NULL
extension	NULL
analysis	NULL
of	NULL
LTR-directed	NULL
mRNA	NULL
from	NULL
the	NULL
TAR-containing	NULL
and	NULL
TAR-deleted	NULL
LTRs	NULL
demonstrates	NULL
that	NULL
transcription	NULL
initiates	NULL
from	NULL
the	NULL
same	NULL
site	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

The	NULL
results	NULL
from	NULL
transient	NULL
transfection	NULL
and	NULL
RNA	NULL
analysis	NULL
indicate	NULL
that	NULL
Tat	NULL
is	NULL
capable	NULL
of	NULL
activating	NULL
LTR	NULL
expression	NULL
in	NULL
a	NULL
TAR-independent	NULL
manner	NULL
.	NULL

Mapping	NULL
the	NULL
promoter	NULL
sequences	NULL
required	NULL
for	NULL
TAR-independent	NULL
transactivation	NULL
To	NULL
identify	NULL
regions	NULL
of	NULL
the	NULL
LTR	NULL
that	NULL
are	NULL
involved	NULL
in	NULL
mediating	NULL
Tat	NULL
activity	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TAR	NULL
,	NULL
a	NULL
series	NULL
of	NULL
deletion	NULL
mutants	NULL
were	NULL
employed	NULL
(	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
each	NULL
of	NULL
these	NULL
constructs	NULL
with	NULL
the	NULL
ptat	NULL
expression	NULL
plasmid	NULL
into	NULL
the	NULL
U87MG	NULL
cell	NULL
line	NULL
allowed	NULL
identification	NULL
of	NULL
LTR	NULL
sequences	NULL
that	NULL
are	NULL
required	NULL
for	NULL
Tat	NULL
responsiveness	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TAR	NULL
.	NULL

Deletion	NULL
of	NULL
5	NULL
'	NULL
LTR	NULL
sequences	NULL
from	NULL
nucleotide	NULL
-	NULL
176	NULL
to	NULL
nucleotide	NULL
-117	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
causes	NULL
a	NULL
slight	NULL
decrease	NULL
in	NULL
basal	NULL
transcription	NULL
[	NULL
as	NULL
has	NULL
been	NULL
previously	NULL
observed	NULL
,	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
]	NULL
,	NULL
but	NULL
does	NULL
not	NULL
influence	NULL
the	NULL
Tat	NULL
responsiveness	NULL
of	NULL
either	NULL
the	NULL
TAR-containing	NULL
(	NULL
pCD23	NULL
)	NULL
or	NULL
the	NULL
TAR-deleted	NULL
LTR	NULL
(	NULL
pCD23ATAR	NULL
)	NULL
(	NULL
Figure	NULL
3A	NULL
and	NULL
B	NULL
,	NULL
lanes	NULL
1-12	NULL
)	NULL
.	NULL

This	NULL
result	NULL
indicates	NULL
that	NULL
sequences	NULL
sufficient	NULL
for	NULL
Tat	NULL
transactivation	NULL
of	NULL
the	NULL
LTR	NULL
within	NULL
these	NULL
cells	NULL
are	NULL
contained	NULL
within	NULL
nucleotides	NULL
-117	NULL
to	NULL
+24	NULL
.	NULL

Construct	NULL
pCD23AS	NULL
contains	NULL
a	NULL
small	NULL
deletion	NULL
in	NULL
the	NULL
region	NULL
corresponding	NULL
to	NULL
the	NULL
boundary	NULL
of	NULL
stem	NULL
and	NULL
loop	NULL
in	NULL
TAR	NULL
(	NULL
nucleotides	NULL
+35	NULL
to	NULL
+38	NULL
)	NULL
,	NULL
and	NULL
otherwise	NULL
leaves	NULL
the	NULL
leader	NULL
sequence	NULL
intact	NULL
.	NULL

Previous	NULL
observations	NULL
have	NULL
demonstrated	NULL
that	NULL
this	NULL
deletion	NULL
abolishes	NULL
Tat	NULL
responsiveness	NULL
in	NULL
non-glial	NULL
cells	NULL
(	NULL
Okamoto	NULL
eral	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

The	NULL
basal	NULL
activity	NULL
of	NULL
Tat	NULL
responsiveness	NULL
of	NULL
pCD23AS	NULL
is	NULL
indistinguishable	NULL
from	NULL
that	NULL
of	NULL
pCD23ATAR	NULL
,	NULL
demonstrating	NULL
that	NULL
the	NULL
level	NULL
of	NULL
transactivation	NULL
observed	NULL
is	NULL
not	NULL
influenced	NULL
by	NULL
the	NULL
length	NULL
of	NULL
the	NULL
leader	NULL
sequence	NULL
(	NULL
Figure	NULL
3A	NULL
and	NULL
B	NULL
,	NULL
lanes	NULL
13-15	NULL
)	NULL
.	NULL

Further	NULL
5	NULL
'	NULL
deletion	NULL
to	NULL
nucleotide	NULL
-65	NULL
results	NULL
in	NULL
a	NULL
reduced	NULL
basal	NULL
transcription	NULL
(	NULL
Figure	NULL
3B	NULL
,	NULL
cf	NULL
.	NULL

lanes	NULL
7	NULL
and	NULL
10	NULL
to	NULL
lanes	NULL
16	NULL
and	NULL
19	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
is	NULL
consistent	NULL
with	NULL
removal	NULL
of	NULL
the	NULL
enhancer	NULL
domain	NULL
(	NULL
present	NULL
between	NULL
nucleotides	NULL
-103	NULL
and	NULL
-80	NULL
)	NULL
.	NULL

Removal	NULL
of	NULL
these	NULL
sequences	NULL
does	NULL
not	NULL
interfere	NULL
with	NULL
Tat	NULL
transactivation	NULL
of	NULL
the	NULL
TAR-containing	NULL
LTR	NULL
(	NULL
pCD52	NULL
)	NULL
,	NULL
but	NULL
abolishes	NULL
Tat	NULL
responsiveness	NULL
of	NULL
the	NULL
TAR-deleted	NULL
LTR	NULL
(	NULL
pCDS2ATAR	NULL
)	NULL
(	NULL
Figure	NULL
3A	NULL
and	NULL
B	NULL
,	NULL
lanes	NULL
16-21	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
sequences	NULL
contained	NULL
within	NULL
nucleotides	NULL
A	NULL
B	NULL
€	NULL
@	NULL
#	NULL
#	NULL
@	NULL
©	NULL
®	NULL
e	NULL
e	NULL
eo	NULL
©	NULL
©	NULL
D	NULL
E	NULL
.	NULL

ha	NULL
E	NULL
a	NULL
3	NULL
900	NULL
5	NULL
:	NULL
_	NULL
$	NULL
is	NULL
Lo	NULL
§	NULL
e	NULL
a	NULL
328	NULL
so	NULL
M	NULL
e	NULL
a	NULL
a	NULL
p	NULL
Fic	NULL
¢	NULL
«	NULL
a	NULL
9	NULL
$	NULL
2g	NULL
=	NULL
a	NULL
€	NULL
a	NULL
&	NULL
&	NULL
a	NULL
a	NULL
a	NULL
§	NULL
$	NULL
5§	NULL
xo	NULL
$	NULL
_	NULL
a	NULL
a	NULL
``	NULL
a	NULL
o	NULL
O	NULL
®	NULL
0	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
1	NULL
2	NULL
D	NULL
'	NULL
.	NULL

a	NULL
E	NULL
3	NULL
«	NULL
a	NULL
a	NULL
m	NULL
_	NULL
a	NULL
s	NULL
oo	NULL
s	NULL
1500	NULL
w	NULL
e	NULL
3	NULL
a.	NULL
,	NULL
1200	NULL
$	NULL
«	NULL
$	NULL
48	NULL
8	NULL
$	NULL
&	NULL
°	NULL
90	NULL
$	NULL
Jax	NULL
a	NULL
,	NULL
a	NULL
m	NULL
a	NULL
5a	NULL
-	NULL
a	NULL
a	NULL
a	NULL
<	NULL
i	NULL
%	NULL
``	NULL
I	NULL
3	NULL
a	NULL
a	NULL
a	NULL
6	NULL
w	NULL
o	NULL
m	NULL
C	NULL
«	NULL
a	NULL
300	NULL
``	NULL
a	NULL
m	NULL
y	NULL
o	NULL
ai	NULL
inl	NULL
ind	NULL
F	NULL
6	NULL
a	NULL
*-	NULL
x~	NULL
o	NULL
_-_	NULL
1	NULL
2	NULL
3	NULL
a	NULL
5	NULL
6	NULL
*e	NULL
#	NULL
*	NULL
®	NULL
«	NULL
@	NULL
<	NULL
#	NULL
|	NULL
a	NULL
«	NULL
a	NULL
a	NULL
s	NULL
=	NULL
jo	NULL
747.3	NULL
£	NULL
130.8	NULL
w	NULL
TAR-independent	NULL
transactivation	NULL
by	NULL
Tat	NULL
0	NULL
-	NULL
@	NULL
°	NULL
@	NULL
<	NULL
b	NULL
n	NULL
-+	NULL
@	NULL
©	NULL
@	NULL
«	NULL
>	NULL
-	NULL
<	NULL
325.8	NULL
£	NULL
37.8	NULL
21.2	NULL
£	NULL
4.1	NULL
80.6	NULL
£	NULL
10.4	NULL
358.9	NULL
£	NULL
34.5	NULL
192.9	NULL
£	NULL
35.7	NULL
112.1	NULL
£	NULL
20.2	NULL
22.4	NULL
£	NULL
2.8	NULL
a	NULL
o	NULL
w	NULL
w	NULL
m	NULL
o	NULL
889.1	NULL
£	NULL
94.1	NULL
13.4	NULL
£	NULL
40.5	NULL
J	NULL
...	NULL
t.	NULL
__	NULL
n	NULL
1175x142	NULL
|	NULL
e	NULL
Ur	NULL
»	NULL
4	NULL
18.8	NULL
a	NULL
8.5	NULL
143	NULL
a	NULL
5.5	NULL
Mllﬂzﬂ	NULL
Mirna	NULL
“	NULL
0va:20	NULL
I	NULL
1-18.5L13	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

(	NULL
A-F	NULL
)	NULL
Dependence	NULL
of	NULL
Tat	NULL
responsiveness	NULL
on	NULL
the	NULL
TAR	NULL
element	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
.	NULL

Either	NULL
the	NULL
wild-type	NULL
HIV-1	NULL
LTR-CAT	NULL
construct	NULL
(	NULL
pCD16	NULL
)	NULL
or	NULL
a	NULL
TAR-deleted	NULL
LTR-CAT	NULL
construct	NULL
(	NULL
pCD16ATAR	NULL
)	NULL
(	NULL
200	NULL
ng	NULL
)	NULL
were	NULL
cotransfected	NULL
with	NULL
0	NULL
,	NULL
1	NULL
or	NULL
5	NULL
ug	NULL
of	NULL
a	NULL
Tat-expressing	NULL
plasmid	NULL
(	NULL
ptat	NULL
)	NULL
.	NULL

Representative	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

Cell	NULL
lines	NULL
:	NULL
(	NULL
A	NULL
)	NULL
U87-MG	NULL
,	NULL
(	NULL
B	NULL
)	NULL
U138-MG	NULL
,	NULL
(	NULL
C	NULL
)	NULL
C6	NULL
,	NULL
(	NULL
D	NULL
)	NULL
H9	NULL
,	NULL
(	NULL
E	NULL
)	NULL
HeLa	NULL
,	NULL
(	NULL
F	NULL
)	NULL
COS.	NULL
Quantitation	NULL
of	NULL
CAT	NULL
assay	NULL
results	NULL
represent	NULL
an	NULL
average	NULL
of	NULL
multiple	NULL
experiments	NULL
.	NULL

Each	NULL
experiment	NULL
was	NULL
repeated	NULL
three	NULL
or	NULL
more	NULL
times	NULL
.	NULL

-117	NULL
to	NULL
-65	NULL
are	NULL
dispensable	NULL
when	NULL
the	NULL
TAR	NULL
element	NULL
is	NULL
intact	NULL
,	NULL
and	NULL
are	NULL
therefore	NULL
not	NULL
strictly	NULL
required	NULL
for	NULL
mediating	NULL
Tat	NULL
activity	NULL
,	NULL
yet	NULL
are	NULL
required	NULL
for	NULL
the	NULL
Tat	NULL
responsiveness	NULL
that	NULL
operates	NULL
independently	NULL
of	NULL
the	NULL
TAR	NULL
element	NULL
.	NULL

The	NULL
identified	NULL
sequence	NULL
encompasses	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
(	NULL
capable	NULL
of	NULL
binding	NULL
the	NULL
inducible	NULL
transcription	NULL
factor	NULL
NF-xB	NULL
)	NULL
(	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
;	NULL
Kawakami	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
and	NULL
a	NULL
GC-rich	NULL
region	NULL
capable	NULL
of	NULL
binding	NULL
the	NULL
transcription	NULL
factor	NULL
Spl	NULL
(	NULL
Jones	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Garcia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
NF-xB	NULL
domain	NULL
as	NULL
the	NULL
element	NULL
mediating	NULL
Tat	NULL
responsiveness	NULL
To	NULL
define	NULL
precisely	NULL
the	NULL
LTR	NULL
sequence	NULL
responsible	NULL
for	NULL
mediating	NULL
TAR-independent	NULL
Tat	NULL
transactivation	NULL
in	NULL
astrocytic	NULL
cells	NULL
,	NULL
a	NULL
series	NULL
of	NULL
PCR-generated	NULL
deletion	NULL
mutants	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
linked	NULL
to	NULL
the	NULL
CAT	NULL
gene	NULL
was	NULL
constructed	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
.	NULL

These	NULL
constructs	NULL
are	NULL
designed	NULL
to	NULL
allow	NULL
sequential	NULL
examination	NULL
of	NULL
small	NULL
segments	NULL
of	NULL
the	NULL
LTR	NULL
within	NULL
the	NULL
region	NULL
spanning	NULL
-117	NULL
to	NULL
-65	NULL
,	NULL
as	NULL
well	NULL
as	NULL
sequences	NULL
downstream	NULL
3397	NULL
J.P.Taylor	NULL
et	NULL
al	NULL
.	NULL

Fig	NULL
.	NULL

2	NULL
.	NULL

Analysis	NULL
of	NULL
RNA	NULL
from	NULL
transiently	NULL
transfected	NULL
U87-MG	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nuclease	NULL
S1	NULL
protection	NULL
analysis	NULL
.	NULL

Cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
indicated	NULL
LTR-CAT	NULL
reporter	NULL
plasmid	NULL
with	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
or	NULL
without	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
5	NULL
ug	NULL
of	NULL
ptat	NULL
.	NULL

Forty-eight	NULL
hours	NULL
post-transfection	NULL
total	NULL
RNA	NULL
was	NULL
prepared	NULL
and	NULL
analysed	NULL
by	NULL
nuclease	NULL
S1	NULL
protection	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
position	NULL
of	NULL
the	NULL
full-length	NULL
458	NULL
nucleotide	NULL
probe	NULL
and	NULL
the	NULL
expected	NULL
256	NULL
nucleotide	NULL
protected	NULL
fragment	NULL
.	NULL

P	NULL
,	NULL
untreated	NULL
S1	NULL
probe	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

To	NULL
control	NULL
for	NULL
RNA	NULL
integrity	NULL
and	NULL
concentration	NULL
20	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
from	NULL
these	NULL
samples	NULL
were	NULL
analysed	NULL
for	NULL
B-actin	NULL
by	NULL
Northern	NULL
analysis	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
segments	NULL
has	NULL
been	NULL
previously	NULL
implicated	NULL
as	NULL
a	NULL
cis-element	NULL
involved	NULL
in	NULL
transcription	NULL
regulation	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
;	NULL
Kawakami	NULL
ert	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Ratnasabapathy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
CAT	NULL
activity	NULL
following	NULL
cotransfection	NULL
of	NULL
these	NULL
constructs	NULL
with	NULL
the	NULL
expression	NULL
plasmid	NULL
B-actin-Tat	NULL
demonstrates	NULL
that	NULL
removal	NULL
of	NULL
sequences	NULL
downstream	NULL
of	NULL
the	NULL
cap	NULL
site	NULL
(	NULL
construct	NULL
p117/3	NULL
)	NULL
or	NULL
upstream	NULL
of	NULL
the	NULL
NF-xB-binding	NULL
domain	NULL
(	NULL
construct	NULL
p105/3	NULL
)	NULL
does	NULL
not	NULL
influence	NULL
TAR-independent	NULL
Tat	NULL
responsiveness	NULL
(	NULL
Figure	NULL
4B	NULL
)	NULL
.	NULL

Removal	NULL
of	NULL
one	NULL
NF-xB-binding	NULL
site	NULL
(	NULL
construct	NULL
p91/3	NULL
)	NULL
reduces	NULL
Tat	NULL
transactivation	NULL
,	NULL
while	NULL
removal	NULL
of	NULL
both	NULL
NF-xB-binding	NULL
sites	NULL
(	NULL
construct	NULL
p80/3	NULL
)	NULL
eliminates	NULL
Tat	NULL
responsiveness	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
NF-xB	NULL
domain	NULL
is	NULL
required	NULL
for	NULL
the	NULL
TAR-independent	NULL
Tat	NULL
transactivation	NULL
observed	NULL
in	NULL
astrocytic	NULL
cells	NULL
.	NULL

The	NULL
NF-xB	NULL
domain	NULL
is	NULL
sufficient	NULL
to	NULL
confer	NULL
Tat	NULL
responsiveness	NULL
to	NULL
a	NULL
heterologous	NULL
promoter	NULL
To	NULL
examine	NULL
whether	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
(	NULL
NF-xB-binding	NULL
domain	NULL
)	NULL
is	NULL
sufficient	NULL
to	NULL
confer	NULL
TAR-independent	NULL
Tat	NULL
responsiveness	NULL
to	NULL
an	NULL
unresponsive	NULL
promoter	NULL
in	NULL
astrocytic	NULL
cells	NULL
,	NULL
this	NULL
sequence	NULL
was	NULL
examined	NULL
in	NULL
a	NULL
heterologous	NULL
background	NULL
.	NULL

A	NULL
number	NULL
of	NULL
hybrid	NULL
promoters	NULL
were	NULL
constructed	NULL
by	NULL
introducing	NULL
the	NULL
NF-xB	NULL
and	NULL
Spl	NULL
binding	NULL
domains	NULL
of	NULL
HIV-1	NULL
to	NULL
the	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
promoter	NULL
for	NULL
mouse	NULL
whey	NULL
acidic	NULL
protein	NULL
(	NULL
WAP	NULL
)	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
.	NULL

Transient	NULL
transfection	NULL
assay	NULL
of	NULL
these	NULL
constructs	NULL
demonstrated	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
NF-xB	NULL
domain	NULL
is	NULL
sufficient	NULL
to	NULL
confer	NULL
TAR-independent	NULL
Tat	NULL
responsiveness	NULL
in	NULL
US7MG	NULL
cells	NULL
(	NULL
Figure	NULL
4B	NULL
)	NULL
.	NULL

Transcription	NULL
directed	NULL
by	NULL
the	NULL
NF-xB-containing	NULL
WAP	NULL
promoter	NULL
is	NULL
enhanced	NULL
~6-fold	NULL
by	NULL
Tat	NULL
.	NULL

This	NULL
level	NULL
of	NULL
induction	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
for	NULL
the	NULL
TAR-deleted	NULL
HIV-1	NULL
3398	NULL
promoter	NULL
in	NULL
US7MG	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
construct	NULL
in	NULL
which	NULL
the	NULL
inserted	NULL
NF-xB	NULL
domain	NULL
is	NULL
mutated	NULL
(	NULL
GGGACTTTCC	NULL
altered	NULL
to	NULL
CTCACTTTCC	NULL
)	NULL
is	NULL
not	NULL
responsive	NULL
to	NULL
Tat	NULL
;	NULL
this	NULL
suggests	NULL
that	NULL
a	NULL
specific	NULL
interaction	NULL
with	NULL
this	NULL
region	NULL
is	NULL
involved	NULL
in	NULL
Tat	NULL
responsiveness	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
the	NULL
Spl	NULL
domain	NULL
in	NULL
the	NULL
chimeric	NULL
WAP	NULL
promoter	NULL
has	NULL
no	NULL
significant	NULL
influence	NULL
on	NULL
Tat	NULL
responsiveness	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
NF-xB	NULL
domain	NULL
,	NULL
but	NULL
seems	NULL
to	NULL
contribute	NULL
to	NULL
a	NULL
slightly	NULL
greater	NULL
Tat	NULL
responsiveness	NULL
when	NULL
the	NULL
NF-xB	NULL
and	NULL
Spl	NULL
domains	NULL
are	NULL
both	NULL
present	NULL
.	NULL

In	NULL
the	NULL
H9	NULL
lymphoid	NULL
cell	NULL
line	NULL
these	NULL
hybrid	NULL
promoter	NULL
constructs	NULL
are	NULL
all	NULL
unresponsive	NULL
to	NULL
Tat	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Comparison	NULL
of	NULL
NF-xB-binding	NULL
activity	NULL
of	NULL
glial	NULL
cells	NULL
to	NULL
the	NULL
'classic	NULL
'	NULL
NF-xB	NULL
of	NULL
T	NULL
lymphoid	NULL
cells	NULL
The	NULL
NF-xB	NULL
domain	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
consists	NULL
of	NULL
a	NULL
DNA	NULL
sequence	NULL
motif	NULL
that	NULL
is	NULL
shared	NULL
among	NULL
a	NULL
variety	NULL
of	NULL
viral	NULL
and	NULL
cellular	NULL
genes	NULL
(	NULL
see	NULL
Baeuerle	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
for	NULL
a	NULL
review	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
this	NULL
DNA	NULL
element	NULL
have	NULL
been	NULL
intensely	NULL
studied	NULL
because	NULL
of	NULL
their	NULL
role	NULL
in	NULL
inducing	NULL
the	NULL
expression	NULL
of	NULL
immune	NULL
response	NULL
genes	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
the	NULL
NF-xB	NULL
domain	NULL
mediates	NULL
Tat	NULL
responsiveness	NULL
in	NULL
US7MG	NULL
cells	NULL
led	NULL
us	NULL
to	NULL
examine	NULL
NF-xB-binding	NULL
activity	NULL
in	NULL
this	NULL
glial	NULL
cell	NULL
line	NULL
.	NULL

DNA	NULL
band-shift	NULL
analysis	NULL
demonstrates	NULL
a	NULL
pattern	NULL
of	NULL
two	NULL
complexes	NULL
(	NULL
labelled	NULL
a	NULL
and	NULL
B	NULL
in	NULL
Figure	NULL
5	NULL
)	NULL
,	NULL
both	NULL
enhanced	NULL
by	NULL
PMA	NULL
stimulation	NULL
(	NULL
Figure	NULL
5A	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
which	NULL
is	NULL
specifically	NULL
competed	NULL
out	NULL
by	NULL
wild-type	NULL
oligonucleotide	NULL
but	NULL
not	NULL
mutant	NULL
oligonucleotide	NULL
(	NULL
GGGACTTTCC	NULL
altered	NULL
to	NULL
CTCACTTTCC	NULL
)	NULL
(	NULL
Figure	NULL
5B	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
however	NULL
,	NULL
the	NULL
mobility	NULL
of	NULL
these	NULL
two	NULL
complexes	NULL
differs	NULL
greatly	NULL
from	NULL
the	NULL
mobility	NULL
of	NULL
NF-xB	NULL
complexes	NULL
derived	NULL
from	NULL
T	NULL
lymphoid	NULL
cells	NULL
(	NULL
Figure	NULL
5A	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
a	NULL
band	NULL
seems	NULL
to	NULL
be	NULL
common	NULL
to	NULL
both	NULL
extracts	NULL
,	NULL
the	NULL
3	NULL
band	NULL
appears	NULL
to	NULL
exist	NULL
only	NULL
in	NULL
glial	NULL
cell	NULL
extracts	NULL
.	NULL

This	NULL
result	NULL
implies	NULL
that	NULL
additional	NULL
,	NULL
or	NULL
perhaps	NULL
entirely	NULL
different	NULL
,	NULL
NF-xB-binding	NULL
activities	NULL
are	NULL
present	NULL
in	NULL
glial	NULL
cells	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
exogenous	NULL
Tat	NULL
protein	NULL
to	NULL
glial	NULL
nuclear	NULL
extracts	NULL
,	NULL
and	NULL
examination	NULL
of	NULL
extracts	NULL
prepared	NULL
from	NULL
glial	NULL
cells	NULL
constitutively	NULL
expressing	NULL
Tat	NULL
,	NULL
revealed	NULL
no	NULL
obvious	NULL
influence	NULL
on	NULL
the	NULL
binding	NULL
of	NULL
glial-derived	NULL
NF-xB	NULL
or	NULL
the	NULL
migration	NULL
of	NULL
the	NULL
&	NULL
and	NULL
(	NULL
3	NULL
complexes	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
an	NULL
indirect	NULL
role	NULL
for	NULL
Tat	NULL
in	NULL
influencing	NULL
NF-xB-binding	NULL
activity	NULL
.	NULL

Binding	NULL
analyses	NULL
using	NULL
highly	NULL
purified	NULL
xB-binding	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
from	NULL
glial	NULL
cells	NULL
and	NULL
analysis	NULL
of	NULL
in	NULL
vitro	NULL
,	NULL
cell-free	NULL
transcription	NULL
are	NULL
essential	NULL
to	NULL
define	NULL
the	NULL
role	NULL
of	NULL
these	NULL
factors	NULL
,	NULL
if	NULL
any	NULL
,	NULL
in	NULL
mediating	NULL
activation	NULL
of	NULL
LTR-directed	NULL
transcription	NULL
by	NULL
Tat	NULL
(	NULL
J.P.Taylor	NULL
,	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

Ability	NULL
of	NULL
the	NULL
upstream	NULL
Tat-responsive	NULL
element	NULL
to	NULL
support	NULL
viral	NULL
replication	NULL
To	NULL
examine	NULL
the	NULL
biological	NULL
significance	NULL
of	NULL
the	NULL
transfection	NULL
assay	NULL
results	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
upstream	NULL
Tat-responsive	NULL
element	NULL
to	NULL
support	NULL
replication	NULL
of	NULL
whole	NULL
virus	NULL
in	NULL
astrocytic	NULL
cell	NULL
lines	NULL
.	NULL

U87MG	NULL
cells	NULL
are	NULL
found	NULL
to	NULL
permit	NULL
normal	NULL
gene	NULL
expression	NULL
of	NULL
wild-type	NULL
HIV-1	NULL
[	NULL
RIP-7	NULL
derivative	NULL
of	NULL
HXB2	NULL
(	NULL
McCune	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
]	NULL
.	NULL

Under	NULL
light	NULL
microscopy	NULL
,	NULL
scattered	NULL
syncytia	NULL
are	NULL
observed	NULL
that	NULL
range	NULL
from	NULL
a	NULL
few	NULL
to	NULL
a	NULL
hundred	NULL
fused	NULL
cells	NULL
(	NULL
Figure	NULL
6A	NULL
)	NULL
.	NULL

ELISA	NULL
assay	NULL
for	NULL
HIV-1	NULL
p24	NULL
antigen	NULL
production	NULL
indicates	NULL
that	NULL
in	NULL
US87MG	NULL
cells	NULL
late	NULL
gene	NULL
expression	NULL
occurs	NULL
at	NULL
lower	NULL
levels	NULL
but	NULL
with	NULL
similar	NULL
kinetics	NULL
to	NULL
that	NULL
seen	NULL
following	NULL
transfection	NULL
of	NULL
H9	NULL
cells	NULL
.	NULL

HIV-1	NULL
p24	NULL
antigen	NULL
production	NULL
reaches	NULL
a	NULL
maximum	NULL
at	NULL
~24	NULL
h	NULL
post-transfection	NULL
with	NULL
the	NULL
wild-type	NULL
proviral	NULL
clone	NULL
in	NULL
H9	NULL
and	NULL
US7MG	NULL
cells	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
and	NULL
decreases	NULL
gradually	NULL
over	NULL
the	NULL
10	NULL
days	NULL
post-transfection	NULL
(	NULL
R.Pomerantz	NULL
,	NULL
submitted	NULL
)	NULL
.	NULL

Two	NULL
TAR-independent	NULL
transactivation	NULL
by	NULL
Tat	NULL
TATA	NULL
TAR	NULL
CAT	NULL
«	NULL
176	NULL
--	NULL
--	NULL
--	NULL
--	NULL
________________	NULL
-	NULL
pCD16	NULL
176	NULL
-	NULL
_-	NULL
-	NULL
--	NULL
-	NULL
pCD16ATAR	NULL
F	NULL
0000	NULL
einen	NULL
emesis	NULL
-	NULL
--	NULL
-	NULL
pCD23	NULL
o	NULL
___	NULL
pCD23ATAR	NULL
2	NULL
_-	NULL
pCD23AS	NULL
-65	NULL
-	NULL
--	NULL
--	NULL
--	NULL
-	NULL
pCD52	NULL
65	NULL
--	NULL
e	NULL
>	NULL
--	NULL
--	NULL
--	NULL
-pCD52ATAR	NULL
B	NULL
pCD16	NULL
_	NULL
pCD16ATAR	NULL
pCD52	NULL
_	NULL
pCDS52ATAR	NULL
pot	NULL
o	NULL
--	NULL
howe	NULL
~	NULL
Po	NULL
-I	NULL
_-	NULL
plat	NULL
w	NULL
»	NULL
o	NULL
@	NULL
*	NULL
&	NULL
o	NULL
o	NULL
o	NULL
99	NULL
e	NULL
Stat	NULL
*	NULL
plat	NULL
]	NULL
«	NULL
«	NULL
:	NULL
_-	NULL
ptat|	NULL
é	NULL
#	NULL
9	NULL
o	NULL
o	NULL
o	NULL
@	NULL
a	NULL
16	NULL
17	NULL
18	NULL
19	NULL
20	NULL
21	NULL
Fold	NULL
Transactivation	NULL
:	NULL
-	NULL
16.6	NULL
18.1	NULL
3.1	NULL
25.7	NULL
30.1	NULL
0.78	NULL
0.91	NULL
hd	NULL
x	NULL
o	NULL
en	NULL
s	NULL
]	NULL
=	NULL
+	NULL
a	NULL
o	NULL
&	NULL
a	NULL
0	NULL
%	NULL
6	NULL
co	NULL
+	NULL
\o	NULL
¢	NULL
z	NULL
-	NULL
wo4	NULL
ike	NULL
cmm	NULL
2	NULL
500	NULL
€	NULL
..	NULL
al	NULL
oi	NULL
M	NULL
a	NULL
a	NULL
bu	NULL
&	NULL
s	NULL
od	NULL
a	NULL
$	NULL
243	NULL
40	NULL
e	NULL
e	NULL
oa	NULL
o	NULL
a	NULL
B	NULL
s	NULL
B	NULL
&	NULL
4	NULL
~	NULL
fo	NULL
5	NULL
<	NULL
2	NULL
e	NULL
300	NULL
{	NULL
|	NULL
3	NULL
%	NULL
o	NULL
=	NULL
%	NULL
o	NULL
2	NULL
g	NULL
e	NULL
T7	NULL
p	NULL
50	NULL
*A	NULL
§	NULL
a	NULL
w	NULL
en	NULL
#	NULL
wi	NULL
wl	NULL
a	NULL
w	NULL
+	NULL
s	NULL
«	NULL
:	NULL
x	NULL
,	NULL
be	NULL
25	NULL
g	NULL
200	NULL
«	NULL
«	NULL
a	NULL
o	NULL
«	NULL
a	NULL
pes	NULL
o	NULL
«	NULL
m	NULL
-	NULL
=	NULL
3	NULL
o	NULL
o	NULL
_o	NULL
a*	NULL
§	NULL
°	NULL
R	NULL
a	NULL
_	NULL
&	NULL
no	NULL
$	NULL
$	NULL
A	NULL
_	NULL
®	NULL
#	NULL
000	NULL
+4	NULL
p	NULL
100	NULL
<	NULL
w	NULL
Po	NULL
s	NULL
a	NULL
o	NULL
,	NULL
x	NULL
0	NULL
%	NULL
€	NULL
m	NULL
i-	NULL
o	NULL
a	NULL
f	NULL
bo	NULL
uo	NULL
a	NULL
ta	NULL
&	NULL
s	NULL
co	NULL
'	NULL
o	NULL
5	NULL
es	NULL
G	NULL
g	NULL
&	NULL
7	NULL
e	NULL
es	NULL
to	NULL
o	NULL
m	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Targeting	NULL
the	NULL
Tat-responsive	NULL
element	NULL
.	NULL

(	NULL
A	NULL
)	NULL
LTR-CAT	NULL
deletion	NULL
constructs	NULL
(	NULL
not	NULL
drawn	NULL
to	NULL
scale	NULL
)	NULL
.	NULL

kB	NULL
,	NULL
NF-xB-binding	NULL
site	NULL
(	NULL
nucleotides	NULL
-80	NULL
to	NULL
-104	NULL
)	NULL
;	NULL
Sp1	NULL
,	NULL
GC-rich	NULL
region	NULL
capable	NULL
of	NULL
binding	NULL
the	NULL
transcription	NULL
factor	NULL
Sp1	NULL
;	NULL
TATA	NULL
,	NULL
putative	NULL
TATA	NULL
box	NULL
;	NULL
TAR	NULL
,	NULL
transactivation	NULL
responsive	NULL
element	NULL
.	NULL

All	NULL
numbering	NULL
is	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
which	NULL
is	NULL
designated	NULL
+1	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Transient	NULL
transfection	NULL
and	NULL
CAT	NULL
assay	NULL
analysis	NULL
of	NULL
the	NULL
deletion	NULL
constructs	NULL
in	NULL
U87-MG	NULL
cells	NULL
.	NULL

The	NULL
indicated	NULL
LTR-CAT	NULL
constructs	NULL
(	NULL
300	NULL
ng	NULL
)	NULL
were	NULL
cotransfected	NULL
with	NULL
0	NULL
,	NULL
1	NULL
or	NULL
5	NULL
ug	NULL
of	NULL
ptat	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Quantitation	NULL
of	NULL
CAT	NULL
assay	NULL
results	NULL
represent	NULL
an	NULL
average	NULL
of	NULL
five	NULL
to	NULL
eight	NULL
independent	NULL
experiments	NULL
.	NULL

Each	NULL
experiment	NULL
was	NULL
repeated	NULL
three	NULL
or	NULL
more	NULL
times	NULL
.	NULL

FOLD	NULL
TRANSACTIVATION	NULL
-o	NULL
-	NULL
n	NULL
3	NULL
8	NULL
ke	NULL
S01	NULL
tata	NULL
+l	NULL
tan	NULL
+80	NULL
p117/80	NULL
Ah	NULL
--	NULL
-+24	NULL
p117/24	NULL
+3	NULL
p117/3	NULL
~10§	NULL
--	NULL
--	NULL
--	NULL
--	NULL
+3	NULL
p105/3	NULL
«	NULL
91	NULL
--	NULL
--	NULL
--	NULL
-	NULL
+3	NULL
p91/3	NULL
+80	NULL
--	NULL
-	NULL
+3	NULL
p80/3	NULL
CAAT	NULL
TATA	NULL
86	NULL
--	NULL
mm-aam	NULL
--	NULL
-	NULL
+24	NULL
pWAPCAT	NULL
HJ	NULL
--	NULL
--	NULL
--	NULL
-	NULL
+24	NULL
pGC-WAPCAT	NULL
+24	NULL
pkB-WAPCAT	NULL
OHO	NULL
--	NULL
--	NULL
--	NULL
--	NULL
+24	NULL
pkBpy-WAPCAT	NULL
ma	NULL
BB§	NULL
#	NULL
--	NULL
--	NULL
--	NULL
-	NULL
+24	NULL
pkB/GC-WAPCAT	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Fine	NULL
mapping	NULL
of	NULL
the	NULL
Tat-responsive	NULL
element	NULL
and	NULL
analysis	NULL
in	NULL
a	NULL
heterologous	NULL
background	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Deletion	NULL
constructs	NULL
,	NULL
designed	NULL
to	NULL
sequentially	NULL
examine	NULL
previously	NULL
identified	NULL
promoter	NULL
elements	NULL
,	NULL
and	NULL
hybrid	NULL
promoter	NULL
constructs	NULL
were	NULL
constructed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

Within	NULL
the	NULL
LTR	NULL
the	NULL
NF-kB	NULL
domain	NULL
(	NULL
kB	NULL
)	NULL
,	NULL
GC-rich	NULL
domain	NULL
(	NULL
Spl	NULL
)	NULL
,	NULL
TATA	NULL
box	NULL
(	NULL
TATA	NULL
)	NULL
,	NULL
and	NULL
TAR	NULL
element	NULL
(	NULL
TAR	NULL
)	NULL
are	NULL
identified	NULL
.	NULL

Within	NULL
the	NULL
whey	NULL
acidic	NULL
protein	NULL
promoter	NULL
the	NULL
CAAT	NULL
box	NULL
(	NULL
CAAT	NULL
)	NULL
and	NULL
TATA	NULL
box	NULL
(	NULL
TATA	NULL
)	NULL
are	NULL
identified	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Fold	NULL
transactivation	NULL
by	NULL
Tat	NULL
as	NULL
determined	NULL
by	NULL
transient	NULL
transfection	NULL
analysis	NULL
.	NULL

The	NULL
indicated	NULL
CAT	NULL
constructs	NULL
were	NULL
cotransfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
actin-tat	NULL
.	NULL

3399	NULL
J.P.Taylor	NULL
et	NULL
al	NULL
.	NULL

Fig	NULL
.	NULL

5	NULL
.	NULL

DNA	NULL
band-shift	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
U87MG	NULL
cells	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Comparison	NULL
of	NULL
NF-xB-binding	NULL
activity	NULL
of	NULL
U87MG	NULL
cells	NULL
to	NULL
that	NULL
found	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
unstimulated	NULL
U87MG	NULL
cells	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
U87MG	NULL
cells	NULL
after	NULL
24	NULL
h	NULL
stimulation	NULL
with	NULL
50	NULL
ng/ml	NULL
phorbol-myristic	NULL
acid	NULL
(	NULL
PMA	NULL
)	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
unstimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
after	NULL
24	NULL
h	NULL
stimulation	NULL
with	NULL
PMA	NULL
.	NULL

a	NULL
and	NULL
$	NULL
identify	NULL
two	NULL
complexes	NULL
formed	NULL
upon	NULL
incubation	NULL
of	NULL
U87-MG	NULL
nuclear	NULL
extract	NULL
with	NULL
a	NULL
wild-type	NULL
NF-xB	NULL
probe	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Specificity	NULL
of	NULL
glial-derived	NULL
NF-xB-binding	NULL
factors	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
competition	NULL
with	NULL
100	NULL
ng	NULL
of	NULL
unlabelled	NULL
wild-type	NULL
NF-xB	NULL
oligonucleotide	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
competition	NULL
with	NULL
100	NULL
ng	NULL
of	NULL
unlabelled	NULL
mutant	NULL
NF-xB	NULL
oligonucleotide	NULL
.	NULL

mutant	NULL
proviral	NULL
clones	NULL
(	NULL
ATAR1	NULL
and	NULL
ATAR2	NULL
,	NULL
mutant	NULL
derivatives	NULL
of	NULL
HXB2	NULL
RIP-7	NULL
)	NULL
that	NULL
contain	NULL
deletions	NULL
within	NULL
the	NULL
TAR	NULL
element	NULL
were	NULL
utilized	NULL
.	NULL

It	NULL
has	NULL
been	NULL
previously	NULL
demonstrated	NULL
that	NULL
neither	NULL
of	NULL
the	NULL
mutant	NULL
derivatives	NULL
is	NULL
able	NULL
to	NULL
productively	NULL
infect	NULL
lymphoid	NULL
cells	NULL
.	NULL

Indeed	NULL
,	NULL
we	NULL
observed	NULL
no	NULL
evidence	NULL
of	NULL
late	NULL
viral	NULL
gene	NULL
expression	NULL
in	NULL
H9	NULL
cells	NULL
with	NULL
either	NULL
TAR-deleted	NULL
virus	NULL
for	NULL
10	NULL
days	NULL
post-transfection	NULL
.	NULL

Repeated	NULL
assays	NULL
for	NULL
HIV-1	NULL
p24	NULL
antigen	NULL
production	NULL
were	NULL
negative	NULL
(	NULL
Figure	NULL
7A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
following	NULL
transfection	NULL
of	NULL
the	NULL
ATAR1	NULL
and	NULL
ATAR2	NULL
mutants	NULL
into	NULL
US7MG	NULL
cells	NULL
,	NULL
substantial	NULL
p24	NULL
expression	NULL
was	NULL
observed	NULL
(	NULL
Figure	NULL
7B	NULL
)	NULL
.	NULL

Consistent	NULL
results	NULL
were	NULL
observed	NULL
following	NULL
transfection	NULL
of	NULL
the	NULL
ATAR	NULL
mutants	NULL
into	NULL
U138MG	NULL
cells	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

The	NULL
syncytia	NULL
observed	NULL
following	NULL
transfection	NULL
of	NULL
U87MG	NULL
cells	NULL
with	NULL
the	NULL
ATAR	NULL
proviruses	NULL
resemble	NULL
those	NULL
produced	NULL
by	NULL
infection	NULL
with	NULL
the	NULL
wild-type	NULL
virus	NULL
(	NULL
Figure	NULL
6B	NULL
)	NULL
.	NULL

The	NULL
ELISA	NULL
assay	NULL
for	NULL
HIV-1	NULL
p24	NULL
antigen	NULL
production	NULL
indicates	NULL
that	NULL
in	NULL
U8S7ZMG	NULL
cells	NULL
late	NULL
gene	NULL
expression	NULL
in	NULL
both	NULL
ATAR1	NULL
and	NULL
ATAR2	NULL
proceeds	NULL
at	NULL
a	NULL
rate	NULL
comparable	NULL
with	NULL
that	NULL
of	NULL
wild-type	NULL
virus	NULL
with	NULL
HIV-1	NULL
p24	NULL
antigen	NULL
production	NULL
reaching	NULL
a	NULL
maximum	NULL
at	NULL
24	NULL
h	NULL
post-transfection	NULL
(	NULL
Figure	NULL
7B	NULL
)	NULL
and	NULL
decreases	NULL
gradually	NULL
over	NULL
the	NULL
10	NULL
days	NULL
post-transfection	NULL
(	NULL
R.Pomerantz	NULL
,	NULL
submitted	NULL
)	NULL
.	NULL

No	NULL
evidence	NULL
of	NULL
syncytia	NULL
formation	NULL
or	NULL
HIV-1	NULL
p24	NULL
production	NULL
was	NULL
detectable	NULL
following	NULL
transfection	NULL
of	NULL
either	NULL
H9	NULL
or	NULL
US7MG	NULL
cells	NULL
with	NULL
a	NULL
Afat	NULL
mutant	NULL
derivative	NULL
of	NULL
HXB2	NULL
RIP-7	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
in	NULL
U87MG	NULL
cells	NULL
,	NULL
as	NULL
in	NULL
non-glial	NULL
cell	NULL
types	NULL
,	NULL
normal	NULL
HIV-1	NULL
gene	NULL
expression	NULL
was	NULL
dependent	NULL
upon	NULL
Tat	NULL
.	NULL

Yet	NULL
in	NULL
the	NULL
astrocytic	NULL
cell	NULL
line	NULL
the	NULL
TAR	NULL
element	NULL
is	NULL
no	NULL
longer	NULL
required	NULL
to	NULL
mediate	NULL
the	NULL
Tat	NULL
effect	NULL
.	NULL

Discussion	NULL
We	NULL
conclude	NULL
that	NULL
a	NULL
Tat-responsive	NULL
element	NULL
within	NULL
the	NULL
LTR	NULL
other	NULL
than	NULL
TAR	NULL
is	NULL
operational	NULL
and	NULL
is	NULL
sufficient	NULL
to	NULL
support	NULL
3400	NULL
normal	NULL
HIV-1	NULL
gene	NULL
expression	NULL
in	NULL
the	NULL
appropriate	NULL
host	NULL
cell	NULL
.	NULL

These	NULL
data	NULL
substantiate	NULL
and	NULL
extend	NULL
the	NULL
observations	NULL
by	NULL
others	NULL
that	NULL
first	NULL
,	NULL
the	NULL
TAR	NULL
element	NULL
is	NULL
not	NULL
strictly	NULL
required	NULL
for	NULL
Tat	NULL
responsiveness	NULL
and	NULL
second	NULL
,	NULL
that	NULL
upstream	NULL
promoter	NULL
elements	NULL
within	NULL
the	NULL
LTR	NULL
are	NULL
involved	NULL
in	NULL
mediating	NULL
Tat	NULL
transactivation	NULL
.	NULL

That	NULL
the	NULL
TAR	NULL
element	NULL
is	NULL
not	NULL
strictly	NULL
required	NULL
for	NULL
Tat	NULL
responsiveness	NULL
has	NULL
been	NULL
demonstrated	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
experiments	NULL
designed	NULL
to	NULL
allow	NULL
Tat	NULL
to	NULL
bypass	NULL
the	NULL
TAR	NULL
binding	NULL
step	NULL
.	NULL

In	NULL
HeLa	NULL
and	NULL
COS	NULL
cells	NULL
Tat	NULL
responsiveness	NULL
can	NULL
be	NULL
restored	NULL
to	NULL
TAR-deleted	NULL
promoters	NULL
by	NULL
providing	NULL
an	NULL
artificial	NULL
target	NULL
for	NULL
Tat	NULL
binding	NULL
within	NULL
the	NULL
LTR	NULL
(	NULL
Berkhout	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Selby	NULL
and	NULL
Peterlin	NULL
,	NULL
1990	NULL
;	NULL
Southgate	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Southgate	NULL
and	NULL
Green	NULL
,	NULL
1991	NULL
;	NULL
Kamine	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Further	NULL
,	NULL
in	NULL
certain	NULL
PMA-stimulated	NULL
lymphoid	NULL
cells	NULL
,	NULL
TAR-independent	NULL
transactivation	NULL
of	NULL
the	NULL
LTR	NULL
has	NULL
been	NULL
observed	NULL
and	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
(	NULL
Harrich	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

From	NULL
these	NULL
studies	NULL
it	NULL
has	NULL
been	NULL
generally	NULL
concluded	NULL
that	NULL
the	NULL
TAR	NULL
element	NULL
functions	NULL
primarily	NULL
as	NULL
a	NULL
tether	NULL
for	NULL
Tat	NULL
,	NULL
bringing	NULL
this	NULL
transcription	NULL
factor	NULL
into	NULL
the	NULL
proximity	NULL
of	NULL
basal	NULL
transcription	NULL
elements	NULL
and	NULL
allowing	NULL
optimal	NULL
access	NULL
to	NULL
the	NULL
transcriptional	NULL
machinery	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
demonstrate	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
in	NULL
a	NULL
cell	NULL
type-specific	NULL
manner	NULL
,	NULL
transactivation	NULL
by	NULL
Tat	NULL
occurs	NULL
independently	NULL
of	NULL
the	NULL
TAR	NULL
element	NULL
without	NULL
artificial	NULL
perturbation	NULL
,	NULL
suggesting	NULL
that	NULL
an	NULL
alternative	NULL
mechanism	NULL
of	NULL
recruitment	NULL
of	NULL
Tat	NULL
to	NULL
the	NULL
promoter	NULL
is	NULL
at	NULL
work	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
hypothesis	NULL
we	NULL
have	NULL
noted	NULL
interesting	NULL
results	NULL
with	NULL
Tat	NULL
mutants	NULL
that	NULL
have	NULL
the	NULL
basic	NULL
domain	NULL
altered	NULL
so	NULL
that	NULL
they	NULL
are	NULL
no	NULL
longer	NULL
capable	NULL
of	NULL
binding	NULL
TAR	NULL
.	NULL

These	NULL
Tat	NULL
mutants	NULL
are	NULL
unable	NULL
to	NULL
transactivate	NULL
LTR-directed	NULL
transcription	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
Calnan	NULL
eral	NULL
.	NULL

,	NULL
1991b	NULL
)	NULL
but	NULL
are	NULL
functional	NULL
in	NULL
the	NULL
background	NULL
of	NULL
astrocytic	NULL
cells	NULL
(	NULL
J.P.	NULL
Taylor	NULL
,	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
identified	NULL
as	NULL
responsible	NULL
for	NULL
TAR-independent	NULL
Tat	NULL
responsiveness	NULL
in	NULL
astrocytic	NULL
cells	NULL
is	NULL
capable	NULL
of	NULL
binding	NULL
the	NULL
transcription	NULL
factor	NULL
NF-xB	NULL
,	NULL
an	NULL
interaction	NULL
that	NULL
correlates	NULL
with	NULL
activation	NULL
of	NULL
LTR-directed	NULL
transcription	NULL
(	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
;	NULL
Kawakami	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

Evidence	NULL
from	NULL
one	NULL
study	NULL
suggests	NULL
that	NULL
this	NULL
enhancer	NULL
sequence	NULL
is	NULL
involved	NULL
even	NULL
in	NULL
TAR-dependent	NULL
transactivation	NULL
(	NULL
Berkhout	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
NF-xB	NULL
is	NULL
composed	NULL
of	NULL
a	NULL
number	NULL
of	NULL
factors	NULL
that	NULL
belong	NULL
to	NULL
the	NULL
rel	NULL
family	NULL
of	NULL
proteins	NULL
(	NULL
Baeuerle	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

Different	NULL
members	NULL
of	NULL
the	NULL
rel	NULL
family	NULL
have	NULL
been	NULL
found	NULL
expressed	NULL
in	NULL
a	NULL
cell	NULL
type-specific	NULL
manner	NULL
(	NULL
Baeuerle	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

We	NULL
find	NULL
in	NULL
glial	NULL
cells	NULL
the	NULL
expression	NULL
of	NULL
PMA-inducible	NULL
NF-xB-binding	NULL
complex	NULL
(	NULL
es	NULL
)	NULL
with	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
that	NULL
is	NULL
distinct	NULL
from	NULL
the	NULL
'classic	NULL
'	NULL
NF-xB	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
in	NULL
cell-free	NULL
extracts	NULL
demonstrates	NULL
that	NULL
these	NULL
glial-derived	NULL
NF-xB-binding	NULL
proteins	NULL
activate	NULL
LTR-directed	NULL
transcription	NULL
and	NULL
are	NULL
involved	NULL
in	NULL
mediating	NULL
TAR-independent	NULL
Tat	NULL
transactivation	NULL
(	NULL
J.P.	NULL
Taylor	NULL
,	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

At	NULL
present	NULL
,	NULL
however	NULL
,	NULL
we	NULL
have	NULL
not	NULL
detected	NULL
association	NULL
of	NULL
Tat	NULL
with	NULL
the	NULL
NF-xB	NULL
complex	NULL
derived	NULL
from	NULL
glial	NULL
cells	NULL
utilizing	NULL
our	NULL
current	NULL
assays	NULL
(	NULL
mobility	NULL
shift	NULL
and	NULL
UV	NULL
cross-linking	NULL
)	NULL
.	NULL

Substantial	NULL
quantities	NULL
of	NULL
highly	NULL
purified	NULL
protein	NULL
are	NULL
needed	NULL
to	NULL
examine	NULL
direct	NULL
interaction	NULL
of	NULL
glial-derived	NULL
NF-xB	NULL
with	NULL
Tat	NULL
and	NULL
its	NULL
involvement	NULL
in	NULL
mediating	NULL
transactivation	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
protein	NULL
purification	NULL
and	NULL
cloning	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
glial-derived	NULL
xB	NULL
are	NULL
currently	NULL
underway	NULL
.	NULL

The	NULL
observations	NULL
presented	NULL
here	NULL
can	NULL
be	NULL
added	NULL
to	NULL
the	NULL
substantial	NULL
evidence	NULL
that	NULL
upstream	NULL
promoter	NULL
sequences	NULL
within	NULL
the	NULL
LTR	NULL
are	NULL
involved	NULL
in	NULL
mediating	NULL
Tat	NULL
transactivation	NULL
.	NULL

It	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
the	NULL
GC-rich	NULL
sequences	NULL
found	NULL
between	NULL
the	NULL
enhancer	NULL
and	NULL
the	NULL
TATA	NULL
box	NULL
,	NULL
which	NULL
are	NULL
capable	NULL
of	NULL
binding	NULL
Spl	NULL
,	NULL
are	NULL
required	NULL
for	NULL
TAR-dependent	NULL
trans-	NULL
TAR-independent	NULL
transactivation	NULL
by	NULL
Tat	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Light	NULL
microscopy	NULL
demonstrating	NULL
syncytia	NULL
formation	NULL
.	NULL

U87-MG	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
HIV-1	NULL
wild-type	NULL
proviral	NULL
clone	NULL
HXB2	NULL
RIP-7	NULL
or	NULL
a	NULL
mutant	NULL
derivative	NULL
,	NULL
and	NULL
72	NULL
h	NULL
later	NULL
fixed	NULL
and	NULL
stained	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Transfection	NULL
with	NULL
wild-type	NULL
HXB2	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Transfection	NULL
with	NULL
the	NULL
ATAR1	NULL
deletion	NULL
mutant	NULL
.	NULL

activation	NULL
by	NULL
Tat	NULL
(	NULL
Okamoto	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Kamine	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

In	NULL
a	NULL
provocative	NULL
series	NULL
of	NULL
experiments	NULL
it	NULL
was	NULL
demonstrated	NULL
that	NULL
the	NULL
Sp1-binding	NULL
sites	NULL
could	NULL
be	NULL
functionally	NULL
replaced	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
basal	NULL
transcription	NULL
elements	NULL
in	NULL
permitting	NULL
Tat	NULL
transactivation	NULL
,	NULL
although	NULL
the	NULL
Spl	NULL
element	NULL
was	NULL
optimal	NULL
(	NULL
Southgate	NULL
and	NULL
Green	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
the	NULL
status	NULL
of	NULL
transcriptional	NULL
initiation	NULL
and	NULL
the	NULL
rate	NULL
of	NULL
initiation	NULL
rather	NULL
than	NULL
the	NULL
specific	NULL
factors	NULL
involved	NULL
,	NULL
play	NULL
a	NULL
role	NULL
in	NULL
determining	NULL
responsiveness	NULL
to	NULL
Tat	NULL
.	NULL

These	NULL
observations	NULL
are	NULL
interesting	NULL
in	NULL
light	NULL
of	NULL
the	NULL
results	NULL
presented	NULL
in	NULL
this	NULL
report	NULL
.	NULL

We	NULL
observe	NULL
that	NULL
the	NULL
NF-xB-binding	NULL
domain	NULL
is	NULL
capable	NULL
of	NULL
conferring	NULL
Tat	NULL
responsiveness	NULL
to	NULL
a	NULL
heterologous	NULL
promoter	NULL
,	NULL
but	NULL
that	NULL
the	NULL
Tat	NULL
responsiveness	NULL
of	NULL
this	NULL
promoter	NULL
is	NULL
increased	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
Spl-binding	NULL
sites	NULL
.	NULL

Perhaps	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
Sp1-binding	NULL
sites	NULL
the	NULL
CAAT	NULL
box	NULL
present	NULL
within	NULL
the	NULL
WAP	NULL
promoter	NULL
is	NULL
functionally	NULL
substituting	NULL
for	NULL
the	NULL
‘	NULL
E	NULL
‘	NULL
A	NULL
H9	NULL
B	NULL
U87MG	NULL
&	NULL
3000	NULL
3000	NULL
§	NULL
@	NULL
2000	NULL
2000	NULL
F	NULL
§	NULL
100	NULL
1000	NULL
hos	NULL
&	NULL
o	NULL
OP	NULL
PP	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

HIV-1	NULL
p24	NULL
antigen	NULL
assay	NULL
of	NULL
supernatants	NULL
from	NULL
transfected	NULL
H9	NULL
and	NULL
U87-MG	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
indicated	NULL
proviral	NULL
clone	NULL
and	NULL
analysed	NULL
for	NULL
p24	NULL
production	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

Only	NULL
the	NULL
24	NULL
h	NULL
time	NULL
point	NULL
(	NULL
peak	NULL
production	NULL
)	NULL
is	NULL
shown	NULL
.	NULL

(	NULL
A	NULL
)	NULL
H9	NULL
cells	NULL
,	NULL
(	NULL
B	NULL
)	NULL
U87-MG	NULL
cells	NULL
.	NULL

§of	NULL
$	NULL
d	NULL
<	NULL
a	NULL
3401	NULL
J.P.Taylor	NULL
et	NULL
al	NULL
.	NULL

GC-rich	NULL
sequences	NULL
that	NULL
are	NULL
required	NULL
for	NULL
Tat	NULL
responsiveness	NULL
by	NULL
the	NULL
LTR	NULL
.	NULL

The	NULL
observations	NULL
presented	NULL
here	NULL
support	NULL
the	NULL
proposition	NULL
that	NULL
differential	NULL
utilization	NULL
of	NULL
the	NULL
Tat	NULL
protein	NULL
,	NULL
probably	NULL
regulated	NULL
by	NULL
cellular	NULL
factors	NULL
,	NULL
influences	NULL
the	NULL
HIV-1	NULL
replicative	NULL
cycle	NULL
.	NULL

The	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
such	NULL
cellular	NULL
factors	NULL
,	NULL
or	NULL
their	NULL
level	NULL
of	NULL
activity	NULL
,	NULL
could	NULL
be	NULL
influenced	NULL
by	NULL
cell	NULL
type	NULL
or	NULL
environmental	NULL
stimuli	NULL
.	NULL

Perhaps	NULL
Tat	NULL
functions	NULL
by	NULL
directly	NULL
or	NULL
indirectly	NULL
stabilizing	NULL
the	NULL
interaction	NULL
of	NULL
cellular	NULL
transcription	NULL
factors	NULL
to	NULL
upstream	NULL
promoter	NULL
elements	NULL
.	NULL

Alternatively	NULL
,	NULL
Tat	NULL
could	NULL
play	NULL
some	NULL
role	NULL
in	NULL
regulating	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
promoter-bound	NULL
transcription	NULL
factor	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
in	NULL
some	NULL
circumstances	NULL
Tat	NULL
activates	NULL
HIV-1	NULL
transcription	NULL
independently	NULL
of	NULL
the	NULL
TAR	NULL
element	NULL
may	NULL
have	NULL
implications	NULL
for	NULL
antiviral	NULL
therapies	NULL
that	NULL
are	NULL
aimed	NULL
at	NULL
Tat	NULL
function	NULL
or	NULL
the	NULL
Tat/TAR	NULL
interaction	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
cellular	NULL
factors	NULL
responsible	NULL
for	NULL
the	NULL
TAR-independent	NULL
Tat	NULL
responsiveness	NULL
observed	NULL
in	NULL
glial	NULL
cells	NULL
,	NULL
and	NULL
their	NULL
mechanism	NULL
of	NULL
action	NULL
,	NULL
are	NULL
under	NULL
investigation	NULL
in	NULL
our	NULL
laboratory	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Cell	NULL
culture	NULL
,	NULL
transfections	NULL
and	NULL
CAT	NULL
assays	NULL
U87-MG	NULL
,	NULL
U138-MG	NULL
,	NULL
HeLa	NULL
and	NULL
COS-1	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
DMEM	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
Gibco	NULL
)	NULL
and	NULL
antibiotics	NULL
.	NULL

C6	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
Ham	NULL
's	NULL
F-10	NULL
medium	NULL
supplemented	NULL
with	NULL
15	NULL
%	NULL
horse	NULL
serum	NULL
(	NULL
Gibco	NULL
)	NULL
and	NULL
2.5	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

Cells	NULL
were	NULL
plated	NULL
at	NULL
a	NULL
density	NULL
of	NULL
5	NULL
x	NULL
10°	NULL
cells/6-cm	NULL
dish	NULL
and	NULL
refed	NULL
fresh	NULL
growth	NULL
media	NULL
3	NULL
h	NULL
prior	NULL
to	NULL
transfection	NULL
by	NULL
the	NULL
calcium	NULL
phosphate	NULL
coprecipitation	NULL
method	NULL
(	NULL
Graham	NULL
and	NULL
van	NULL
der	NULL
Eb	NULL
,	NULL
1973	NULL
)	NULL
.	NULL

H9	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
.	NULL

H9	NULL
cells	NULL
(	NULL
1	NULL
x	NULL
10	NULL
``	NULL
)	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
(	NULL
Arya	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
)	NULL
.	NULL

Reporter	NULL
plasmid	NULL
(	NULL
200	NULL
ng	NULL
or	NULL
300	NULL
ng	NULL
)	NULL
was	NULL
cotransfected	NULL
with	NULL
1	NULL
,	NULL
5	NULL
or	NULL
10	NULL
ug	NULL
of	NULL
ptat	NULL
or	NULL
actin-tat	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
pRSV-Ggal	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
DNA	NULL
transfected	NULL
was	NULL
normalized	NULL
to	NULL
20	NULL
ug	NULL
using	NULL
pUC19	NULL
DNA	NULL
.	NULL

Forty-eight	NULL
hours	NULL
post-transfection	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
a	NULL
crude	NULL
protein	NULL
extract	NULL
was	NULL
prepared	NULL
by	NULL
freeze	NULL
and	NULL
thaw	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
total	NULL
protein	NULL
(	NULL
100	NULL
ug	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
a	NULL
1	NULL
h	NULL
reaction	NULL
to	NULL
assay	NULL
for	NULL
CAT	NULL
activity	NULL
.	NULL

The	NULL
fold	NULL
transactivation	NULL
was	NULL
quantitated	NULL
by	NULL
scintillation	NULL
counting	NULL
of	NULL
spots	NULL
cut	NULL
from	NULL
the	NULL
TLC	NULL
plate	NULL
.	NULL

The	NULL
transfection	NULL
efficiency	NULL
throughout	NULL
these	NULL
experiments	NULL
was	NULL
monitored	NULL
by	NULL
cotransfection	NULL
with	NULL
pRSV-	NULL
@	NULL
gal	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
Nadia	NULL
Rosenthal	NULL
,	NULL
Boston	NULL
University	NULL
)	NULL
and	NULL
found	NULL
not	NULL
to	NULL
differ	NULL
significantly	NULL
.	NULL

Each	NULL
experiment	NULL
was	NULL
repeated	NULL
three	NULL
or	NULL
more	NULL
times	NULL
with	NULL
different	NULL
plasmid	NULL
preparations	NULL
.	NULL

Plasmids	NULL
and	NULL
oligonucleotides	NULL
All	NULL
cloning	NULL
procedures	NULL
followed	NULL
standard	NULL
protocols	NULL
(	NULL
Maniatis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1982	NULL
)	NULL
.	NULL

Plasmids	NULL
pCD16	NULL
,	NULL
pCD23	NULL
and	NULL
pCDS2	NULL
are	NULL
HIV-1	NULL
LTR	NULL
deletions	NULL
linked	NULL
to	NULL
the	NULL
reporter	NULL
gene	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
and	NULL
are	NULL
shown	NULL
in	NULL
Figure	NULL
3	NULL
.	NULL

Plasmid	NULL
pCD23AS	NULL
contains	NULL
a	NULL
deletion	NULL
of	NULL
nucleotides	NULL
+35	NULL
to	NULL
+38	NULL
(	NULL
Okamoto	NULL
er	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

The	NULL
ATAR	NULL
deletions	NULL
in	NULL
the	NULL
LTR-CAT	NULL
constructs	NULL
(	NULL
pCD16ATAR	NULL
,	NULL
pCD23ATAR	NULL
and	NULL
pCDS2ATAR	NULL
)	NULL
were	NULL
created	NULL
by	NULL
restriction	NULL
digestion	NULL
with	NULL
Bg//HindII	NULL
,	NULL
followed	NULL
by	NULL
blunting	NULL
with	NULL
Klenow	NULL
enzyme	NULL
and	NULL
religation	NULL
.	NULL

The	NULL
resulting	NULL
deletion	NULL
extends	NULL
from	NULL
+24	NULL
to	NULL
+80	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

Plasmids	NULL
p117/3	NULL
,	NULL
p105/3	NULL
,	NULL
p91/3	NULL
and	NULL
p80/3	NULL
were	NULL
constructed	NULL
by	NULL
inserting	NULL
PCR-generated	NULL
fragments	NULL
between	NULL
the	NULL
Xbal	NULL
and	NULL
BamHI	NULL
sites	NULL
in	NULL
the	NULL
polylinker	NULL
of	NULL
the	NULL
promoterless	NULL
plasmid	NULL
pBLCAT3	NULL
(	NULL
Luckow	NULL
and	NULL
Schultz	NULL
,	NULL
1987	NULL
)	NULL
.	NULL

Amplimers	NULL
used	NULL
were	NULL
:	NULL
-117	NULL
5-CGCGTCTAGACGAGCTTTCTACAAGGGAC-3	NULL
'	NULL
-105	NULL
-	NULL
5-CGCGTCTAGAGGGACTTTCCGCTGGGGAC-3	NULL
'	NULL
-91	NULL
-	NULL
5-CGCGTCTAGATGGGGACTTTCCAGGGAGG-3	NULL
'	NULL
-80	NULL
5-CGCGTCTAGACAGGGAGGCGTGGCCTGGG-3	NULL
'	NULL
+3	NULL
5-CGCGGGATCCCCCAGTACAGGCAAAAAGC-3	NULL
'	NULL
Construct	NULL
p117/80	NULL
was	NULL
created	NULL
by	NULL
restriction	NULL
digestion	NULL
of	NULL
pCD23	NULL
with	NULL
HindIII	NULL
,	NULL
followed	NULL
by	NULL
blunting	NULL
with	NULL
Klenow	NULL
enzyme	NULL
and	NULL
further	NULL
digestion	NULL
with	NULL
Xbal	NULL
.	NULL

This	NULL
releases	NULL
a	NULL
fragment	NULL
containing	NULL
HIV-1	NULL
LTR	NULL
sequences	NULL
from	NULL
3402	NULL
-117	NULL
to	NULL
+80	NULL
with	NULL
one	NULL
Xbal	NULL
end	NULL
and	NULL
one	NULL
blunt	NULL
end	NULL
.	NULL

The	NULL
pBLCAT3	NULL
vector	NULL
was	NULL
prepared	NULL
for	NULL
this	NULL
insert	NULL
by	NULL
BamHI	NULL
digestion	NULL
,	NULL
followed	NULL
by	NULL
blunting	NULL
with	NULL
Klenow	NULL
enzyme	NULL
and	NULL
further	NULL
digestion	NULL
with	NULL
Xbal	NULL
.	NULL

Construct	NULL
p117/24	NULL
was	NULL
created	NULL
by	NULL
BgilI	NULL
digestion	NULL
of	NULL
p117/80	NULL
,	NULL
which	NULL
removes	NULL
sequences	NULL
between	NULL
the	NULL
Bg/ll	NULL
site	NULL
in	NULL
the	NULL
HIV-1	NULL
LTR	NULL
(	NULL
+24	NULL
relative	NULL
to	NULL
transcription	NULL
start	NULL
site	NULL
)	NULL
and	NULL
the	NULL
BgilI	NULL
site	NULL
in	NULL
the	NULL
pBLCAT3	NULL
polylinker	NULL
,	NULL
followed	NULL
by	NULL
religation	NULL
.	NULL

Plasmid	NULL
pWAP-CAT	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
Ulrich	NULL
Seibenlist	NULL
)	NULL
contains	NULL
nucleotides	NULL
-88	NULL
to	NULL
+24	NULL
of	NULL
the	NULL
mouse	NULL
WAP	NULL
promoter	NULL
linked	NULL
to	NULL
the	NULL
CAT	NULL
gene	NULL
(	NULL
Schmidt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

pxBWAP-CAT	NULL
contains	NULL
two	NULL
copies	NULL
of	NULL
wild-type	NULL
NF-xB-binding	NULL
site	NULL
from	NULL
the	NULL
HIV-1	NULL
LTR	NULL
(	NULL
nucleotides	NULL
-104	NULL
to	NULL
-79	NULL
)	NULL
inserted	NULL
at	NULL
position	NULL
-86	NULL
of	NULL
pWAP-CAT	NULL
;	NULL
pxBy-WAP-CAT	NULL
contains	NULL
two	NULL
copies	NULL
of	NULL
a	NULL
mutant	NULL
NF-xB-binding	NULL
site	NULL
(	NULL
GGGACTTTCC	NULL
altered	NULL
to	NULL
CTCACTTTCC	NULL
)	NULL
inserted	NULL
at	NULL
position	NULL
-86	NULL
of	NULL
pWAP-CAT	NULL
.	NULL

pGC-WAP-CAT	NULL
contains	NULL
the	NULL
GC-rich	NULL
region	NULL
from	NULL
the	NULL
HIV-1	NULL
LTR	NULL
(	NULL
nucleotides	NULL
-45	NULL
to	NULL
-79	NULL
)	NULL
inserted	NULL
at	NULL
position	NULL
-86	NULL
of	NULL
pWAP-CAT	NULL
.	NULL

pxB/GC-WAP-CAT	NULL
contains	NULL
this	NULL
GC-rich	NULL
region	NULL
inserted	NULL
downstream	NULL
of	NULL
the	NULL
xB	NULL
sites	NULL
,	NULL
upstream	NULL
of	NULL
the	NULL
WAP	NULL
promoter	NULL
in	NULL
pxB-WAP-CAT	NULL
.	NULL

Proviral	NULL
clones	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
Mark	NULL
Feinberg	NULL
,	NULL
Whitehead	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
.	NULL

Provirus	NULL
plasmids	NULL
ATAR1	NULL
and	NULL
ATAR2	NULL
are	NULL
mutant	NULL
derivatives	NULL
of	NULL
HXB2	NULL
RIP-7	NULL
(	NULL
McCune	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

ATARI	NULL
was	NULL
created	NULL
by	NULL
a	NULL
partial	NULL
Sacl	NULL
digest	NULL
(	NULL
single	NULL
cut	NULL
)	NULL
followed	NULL
by	NULL
blunting	NULL
with	NULL
Klenow	NULL
enzyme	NULL
.	NULL

This	NULL
resulted	NULL
in	NULL
the	NULL
removal	NULL
of	NULL
nucleotides	NULL
+35	NULL
to	NULL
+38	NULL
relative	NULL
to	NULL
the	NULL
cap	NULL
site	NULL
and	NULL
affected	NULL
only	NULL
the	NULL
5°	NULL
LTR	NULL
.	NULL

This	NULL
mutation	NULL
is	NULL
equivalent	NULL
to	NULL
that	NULL
in	NULL
pCD23AS	NULL
.	NULL

ATAR2	NULL
was	NULL
created	NULL
by	NULL
a	NULL
partial	NULL
Sacl	NULL
digest	NULL
that	NULL
removed	NULL
the	NULL
nucleotides	NULL
between	NULL
+38	NULL
and	NULL
+187	NULL
in	NULL
the	NULL
5	NULL
'	NULL
LTR	NULL
only	NULL
.	NULL

The	NULL
Atat	NULL
mutant	NULL
derivative	NULL
of	NULL
HXB2	NULL
RIP-7	NULL
contains	NULL
an	NULL
M/xl	NULL
linker	NULL
insertion	NULL
within	NULL
the	NULL
coding	NULL
sequence	NULL
for	NULL
Tat	NULL
(	NULL
Feinberg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

All	NULL
plasmids	NULL
were	NULL
sequenced	NULL
to	NULL
confirm	NULL
correct	NULL
construction	NULL
.	NULL

Oligonucleotides	NULL
used	NULL
in	NULL
band-shift	NULL
analysis	NULL
were	NULL
(	NULL
single	NULL
strand	NULL
shown	NULL
)	NULL
:	NULL
5'-TCGACAGAGGGGACTTTCCGAGAGGC-3	NULL
'	NULL
|	NULL
wild-type	NULL
xB	NULL
site	NULL
5'-TCGACAGAGCTCACTTTCC	NULL
GAGGC-3	NULL
'	NULL
mutant	NULL
xB	NULL
site	NULL
The	NULL
Tat	NULL
expression	NULL
plasmid	NULL
ptat	NULL
has	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
Knight	NULL
er	NULL
a/	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

Actin-Tat	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
a	NULL
PCR-amplified	NULL
fragment	NULL
containing	NULL
the	NULL
coding	NULL
sequence	NULL
for	NULL
the	NULL
86	NULL
amino	NULL
acid	NULL
form	NULL
of	NULL
Tat	NULL
downstream	NULL
of	NULL
the	NULL
human	NULL
-actin	NULL
promoter	NULL
in	NULL
the	NULL
plasmid	NULL
pHFGA-1	NULL
(	NULL
Gunning	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1983	NULL
)	NULL
.	NULL

RNA	NULL
analysis	NULL
Total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
transfected	NULL
cells	NULL
by	NULL
the	NULL
hot-acid	NULL
phenol	NULL
method	NULL
(	NULL
Queen	NULL
and	NULL
Baltimore	NULL
,	NULL
1983	NULL
)	NULL
.	NULL

For	NULL
nuclease	NULL
S1	NULL
analysis	NULL
purified	NULL
RNA	NULL
(	NULL
20	NULL
pg	NULL
)	NULL
and	NULL
labelled	NULL
DNA	NULL
probe	NULL
were	NULL
suspended	NULL
in	NULL
20	NULL
pl	NULL
of	NULL
0.4	NULL
M	NULL
NaCl-O.04	NULL
M	NULL
PIPES	NULL
[	NULL
piperazine-N	NULL
,	NULL
V'bis	NULL
(	NULL
2	NULL
)	NULL
-ethanesulfonic	NULL
acid	NULL
;	NULL
pH	NULL
6.4	NULL
]	NULL
-1.25	NULL
mM	NULL
EDTA-80	NULL
%	NULL
formamide	NULL
and	NULL
heat	NULL
denatured	NULL
at	NULL
65°C	NULL
for	NULL
15	NULL
min	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
transferred	NULL
immediately	NULL
to	NULL
a	NULL
37°C	NULL
water	NULL
bath	NULL
and	NULL
incubated	NULL
overnight	NULL
.	NULL

Hybridizations	NULL
were	NULL
terminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
nine	NULL
volumes	NULL
of	NULL
0.25	NULL
M	NULL
NaCl-0.03	NULL
M	NULL
sodium	NULL
acetate	NULL
(	NULL
pH	NULL
4.6	NULL
)	NULL
-	NULL
1	NULL
mM	NULL
ZnSO	NULL
,	NULL
,	NULL
which	NULL
had	NULL
been	NULL
pre-equilibrated	NULL
to	NULL
4°C	NULL
.	NULL

Nuclease	NULL
S1	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
800	NULL
U/ml	NULL
,	NULL
and	NULL
the	NULL
reaction	NULL
sample	NULL
was	NULL
incubated	NULL
for	NULL
60	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Protected	NULL
DNA	NULL
fragments	NULL
were	NULL
then	NULL
purified	NULL
and	NULL
analysed	NULL
by	NULL
electrophoresis	NULL
in	NULL
a	NULL
denaturing	NULL
acrylamide-urea	NULL
gel	NULL
.	NULL

The	NULL
$	NULL
1	NULL
probe	NULL
consisted	NULL
of	NULL
a	NULL
uniformly	NULL
labelled	NULL
,	NULL
single-stranded	NULL
DNA	NULL
of	NULL
458	NULL
nucleotides	NULL
that	NULL
was	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Khalili	NULL
er	NULL
a/	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
.	NULL

The	NULL
expected	NULL
size	NULL
of	NULL
the	NULL
protected	NULL
fragment	NULL
is	NULL
256	NULL
nucleotides	NULL
.	NULL

For	NULL
Northern	NULL
blot	NULL
analysis	NULL
20	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
was	NULL
run	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose-	NULL
formaldehyde	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
and	NULL
hybridized	NULL
to	NULL
the	NULL
2.1	NULL
kb	NULL
BamHI	NULL
B-actin	NULL
cDNA	NULL
fragment	NULL
derived	NULL
from	NULL
pHFGA-1	NULL
(	NULL
Gunning	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1983	NULL
)	NULL
.	NULL

DNA	NULL
band-shift	NULL
analysis	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
a/	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
.	NULL

The	NULL
procedure	NULL
for	NULL
band-shift	NULL
analysis	NULL
was	NULL
essentially	NULL
as	NULL
described	NULL
by	NULL
Singh	NULL
er	NULL
al	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
.	NULL

P-End-labelled	NULL
wild-type	NULL
xB	NULL
oligonucleotide	NULL
(	NULL
40	NULL
000	NULL
counts	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
8	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
in	NULL
a	NULL
binding	NULL
buffer	NULL
consisting	NULL
of	NULL
10	NULL
mM	NULL
Tris	NULL
pH	NULL
7.4	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
Na-EDTA	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
4	NULL
ug	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
0.5	NULL
mg/ml	NULL
BSA	NULL
and	NULL
3	NULL
mM	NULL
GTP	NULL
.	NULL

Following	NULL
a	NULL
30	NULL
min	NULL
incubation	NULL
on	NULL
ice	NULL
the	NULL
resulting	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
a	NULL
low	NULL
ionic	NULL
6	NULL
%	NULL
native	NULL
polyacrylamide	NULL
gel	NULL
containing	NULL
6.7	NULL
mM	NULL
Tris	NULL
pH	NULL
7.4	NULL
,	NULL
3.3	NULL
mM	NULL
Na-acetate	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
Na-EDTA	NULL
.	NULL

Electrophoresis	NULL
was	NULL
carried	NULL
out	NULL
at	NULL
4°C	NULL
at	NULL
a	NULL
constant	NULL
140	NULL
V	NULL
with	NULL
a	NULL
recirculating	NULL
buffer	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
then	NULL
dried	NULL
and	NULL
autoradiographed	NULL
at	NULL
-70°C	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

HIV-1	NULL
p24	NULL
assay	NULL
and	NULL
cell	NULL
staining	NULL
H9	NULL
,	NULL
U87-MG	NULL
and	NULL
U138-MG	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
indicated	NULL
proviral	NULL
clone	NULL
.	NULL

At	NULL
various	NULL
time	NULL
points	NULL
(	NULL
from	NULL
10	NULL
h	NULL
to	NULL
10	NULL
days	NULL
)	NULL
post-transfection	NULL
aliquots	NULL
of	NULL
supernatant	NULL
were	NULL
analysed	NULL
with	NULL
an	NULL
ELISA	NULL
kit	NULL
for	NULL
HIV-1	NULL
p24	NULL
antigen	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
Du	NULL
Pont	NULL
)	NULL
.	NULL

To	NULL
observe	NULL
syncytia	NULL
formation	NULL
,	NULL
72	NULL
h	NULL
post-transfection	NULL
,	NULL
US7-MG	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
phosphate-buffered	NULL
solution	NULL
,	NULL
fixed	NULL
with	NULL
absolute	NULL
methanol	NULL
,	NULL
Giemsa-Wright	NULL
stained	NULL
,	NULL
and	NULL
photographed	NULL
at	NULL
20	NULL
%	NULL
or	NULL
40	NULL
%	NULL
magnification	NULL
.	NULL

Acknowledgements	NULL
The	NULL
authors	NULL
wish	NULL
to	NULL
express	NULL
their	NULL
appreciation	NULL
to	NULL
Dr	NULL
R.C.Gallo	NULL
,	NULL
Dr	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
and	NULL
members	NULL
of	NULL
their	NULL
labs	NULL
for	NULL
encouragement	NULL
and	NULL
support	NULL
;	NULL
and	NULL
members	NULL
of	NULL
the	NULL
Khalili	NULL
lab	NULL
for	NULL
helpful	NULL
discussion	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grant	NULL
AI00930	NULL
awarded	NULL
to	NULL
R.J.P	NULL
.	NULL

by	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
;	NULL
and	NULL
grants	NULL
CA47996	NULL
awarded	NULL
by	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
A128272	NULL
awarded	NULL
by	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
and	NULL
922-2-6RG	NULL
awarded	NULL
by	NULL
AmFAR	NULL
to	NULL
K.K	NULL
.	NULL

and	NULL
S.A.	NULL
References	NULL
Arya	NULL
,	NULL
S.K	NULL
.	NULL

,	NULL
Guo	NULL
,	NULL
C.	NULL
,	NULL
Josephs	NULL
,	NULL
S.F	NULL
.	NULL

and	NULL
Wong-Staal	NULL
,	NULL
F	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Science	NULL
,	NULL
229	NULL
,	NULL
69-73	NULL
.	NULL

Bacuerle	NULL
,	NULL
P	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
1072	NULL
,	NULL
63-80	NULL
.	NULL

Berkhout	NULL
,	NULL
B.	NULL
,	NULL
Silverman	NULL
,	NULL
R.H	NULL
.	NULL

and	NULL
Jeang.K	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Cell	NULL
,	NULL
59	NULL
,	NULL
273-282	NULL
.	NULL

Berkhout	NULL
,	NULL
B.	NULL
,	NULL
Gatignol	NULL
,	NULL
A.	NULL
,	NULL
Rabson	NULL
,	NULL
A.B	NULL
.	NULL

and	NULL
Jeang.K	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
,	NULL
62	NULL
,	NULL
757-767	NULL
.	NULL

Calnan	NULL
,	NULL
B.J	NULL
.	NULL

,	NULL
Biancalana	NULL
,	NULL
$	NULL
.	NULL

,	NULL
Hudson	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Frankel	NULL
,	NULL
A.D.	NULL
(	NULL
1991a	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
5	NULL
,	NULL
201-210	NULL
.	NULL

Calnan	NULL
,	NULL
B.J	NULL
.	NULL

,	NULL
Tidor	NULL
,	NULL
B.	NULL
,	NULL
Biancalana	NULL
,	NULL
S.	NULL
,	NULL
Hudson	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Frankel	NULL
.	NULL

A.D.	NULL
(	NULL
1991b	NULL
)	NULL
Science	NULL
,	NULL
252	NULL
,	NULL
1167-1171	NULL
.	NULL

Cheng-Mayer	NULL
,	NULL
C.	NULL
,	NULL
Rutka	NULL
,	NULL
J.T	NULL
.	NULL

,	NULL
Rosenblum	NULL
,	NULL
M.L	NULL
.	NULL

,	NULL
McHugh	NULL
,	NULL
T.	NULL
,	NULL
Stites	NULL
,	NULL
D.P	NULL
.	NULL

and	NULL
Levy	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
84	NULL
,	NULL
3526-3530	NULL
.	NULL

Chiodi	NULL
,	NULL
F.	NULL
$	NULL
.	NULL

,	NULL
Fuerstenberg	NULL
,	NULL
$	NULL
.	NULL

,	NULL
Gidlund.M	NULL
.	NULL

,	NULL
Asjo	NULL
,	NULL
B	NULL
.	NULL

and	NULL
Fenyo	NULL
,	NULL
E.M	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
61	NULL
,	NULL
1244-1247	NULL
.	NULL

Cullen	NULL
,	NULL
B.R	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
,	NULL
63	NULL
,	NULL
655-657	NULL
.	NULL

Cullen	NULL
,	NULL
B.R	NULL
.	NULL

and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
,	NULL
58	NULL
,	NULL
423-426	NULL
.	NULL

Dayton	NULL
,	NULL
A.1	NULL
.	NULL

,	NULL
Sodroski	NULL
,	NULL
J.G	NULL
.	NULL

,	NULL
Rosen	NULL
,	NULL
C.A	NULL
.	NULL

,	NULL
Goh	NULL
,	NULL
W.C.	NULL
and	NULL
Haseltine	NULL
,	NULL
W.	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Cell	NULL
,	NULL
44	NULL
,	NULL
941-947	NULL
.	NULL

Dewhurst	NULL
,	NULL
$	NULL
.	NULL

,	NULL
Sakai	NULL
,	NULL
K.	NULL
,	NULL
Bresser	NULL
,	NULL
J.	NULL
,	NULL
Stevenson	NULL
,	NULL
M.	NULL
,	NULL
Evinger-Hodges	NULL
.	NULL

M.J.	NULL
and	NULL
Volsky	NULL
,	NULL
D.J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
61	NULL
,	NULL
3774-3782	NULL
.	NULL

Dignam	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
Lebovitz	NULL
,	NULL
R.M	NULL
.	NULL

and	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
11	NULL
,	NULL
1475-1489	NULL
.	NULL

Dingwall	NULL
,	NULL
C	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
,	NULL
6925-6929	NULL
.	NULL

Epstein	NULL
,	NULL
L.G	NULL
.	NULL

,	NULL
Sharer	NULL
,	NULL
L.R	NULL
.	NULL

,	NULL
Joshi	NULL
,	NULL
V.	NULL
V.	NULL
,	NULL
Fojas	NULL
,	NULL
M.M	NULL
.	NULL

,	NULL
Koenigsberger	NULL
,	NULL
MR.	NULL
and	NULL
Oleske	NULL
,	NULL
J.M	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Ann	NULL
.	NULL

Neurol	NULL
.	NULL

,	NULL
17	NULL
,	NULL
488-496	NULL
.	NULL

Feinberg	NULL
.	NULL

M.B	NULL
.	NULL

,	NULL
Baltimore	NULL
,	NULL
D.	NULL
and	NULL
Frankel	NULL
,	NULL
A.D.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
,	NULL
4045-4049	NULL
.	NULL

Feng	NULL
,	NULL
$	NULL
S	NULL
.	NULL

and	NULL
Holland	NULL
,	NULL
E.C	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Nature	NULL
,	NULL
334	NULL
,	NULL
165-167	NULL
.	NULL

Fisher	NULL
,	NULL
.	NULL

A.G.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Nature	NULL
,	NULL
320	NULL
,	NULL
367-371	NULL
.	NULL

Gabuzda	NULL
,	NULL
D.H	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J	NULL
.	NULL

Am	NULL
.	NULL

Acad	NULL
.	NULL

Dermatol	NULL
.	NULL

,	NULL
22	NULL
,	NULL
1232-1236	NULL
.	NULL

Garcia	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
Wu	NULL
,	NULL
F.	NULL
,	NULL
Mitsuyasu	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Gaynor	NULL
,	NULL
R.B	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Embo	NULL
J.	NULL
,	NULL
3761-3770	NULL
.	NULL

Giulian	NULL
,	NULL
D.	NULL
,	NULL
Vaca.K	NULL
.	NULL

and	NULL
Noonan	NULL
,	NULL
C	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Science	NULL
,	NULL
250	NULL
,	NULL
1593-1596	NULL
.	NULL

Graham	NULL
,	NULL
F.L	NULL
.	NULL

and	NULL
van	NULL
der	NULL
Eb	NULL
,	NULL
A.J	NULL
.	NULL

(	NULL
1973	NULL
)	NULL
Virology	NULL
,	NULL
52	NULL
,	NULL
456-467	NULL
.	NULL

Gunning.P	NULL
.	NULL

,	NULL
Ponte.P	NULL
.	NULL

,	NULL
Okayama	NULL
,	NULL
H.	NULL
,	NULL
Engel	NULL
,	NULL
J..	NULL
Blau.H	NULL
.	NULL

and	NULL
Kedes	NULL
,	NULL
L	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
3	NULL
,	NULL
787-795	NULL
.	NULL

Gyorkey	NULL
,	NULL
F.	NULL
,	NULL
Melnick	NULL
,	NULL
J.L	NULL
.	NULL

and	NULL
Gyorkey	NULL
,	NULL
P	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

,	NULL
155	NULL
,	NULL
870-876	NULL
.	NULL

Harrich	NULL
,	NULL
D.	NULL
,	NULL
Garcia	NULL
,	NULL
J.	NULL
,	NULL
Mitsuyasu	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Gaynor	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
9	NULL
,	NULL
4417-4423	NULL
.	NULL

Hauber	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Cullen	NULL
,	NULL
B.R	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
62	NULL
,	NULL
673-679	NULL
.	NULL

Ho	NULL
,	NULL
D.D	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
N.	NULL
Engl	NULL
.	NULL

J	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
313	NULL
,	NULL
1493	NULL
.	NULL

Jones	NULL
,	NULL
K.A	NULL
.	NULL

,	NULL
Kadonga	NULL
,	NULL
J.T	NULL
.	NULL

,	NULL
Luciw	NULL
,	NULL
P	NULL
.	NULL

A.	NULL
and	NULL
Tjian	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Science	NULL
,	NULL
232	NULL
,	NULL
755-759	NULL
.	NULL

Kamine	NULL
,	NULL
J.	NULL
,	NULL
Subramanian	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Chinnadurai	NULL
,	NULL
.G	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
,	NULL
8510-8514	NULL
.	NULL

Kawakami	NULL
,	NULL
K.	NULL
,	NULL
Scheidereit	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Nat	NULL
!	NULL

.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
85	NULL
,	NULL
4700-4704	NULL
.	NULL

Khalili	NULL
,	NULL
K.	NULL
,	NULL
Khoury	NULL
,	NULL
G	NULL
.	NULL

and	NULL
Brady	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
60	NULL
,	NULL
935-942	NULL
.	NULL

Knight.D.M	NULL
.	NULL

,	NULL
Flomerpelt	NULL
,	NULL
F.A	NULL
.	NULL

and	NULL
Ghrayeb.J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Science	NULL
,	NULL
236	NULL
,	NULL
837-840	NULL
.	NULL

Koenig	NULL
,	NULL
$	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Science	NULL
,	NULL
233	NULL
,	NULL
1089-1093	NULL
.	NULL

Laspia	NULL
,	NULL
M.F	NULL
.	NULL

,	NULL
Rice	NULL
,	NULL
A.P	NULL
.	NULL

and	NULL
Mathews	NULL
,	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
,	NULL
59	NULL
,	NULL
283-292	NULL
.	NULL

Laspia.M.F..	NULL
Rice.A.P	NULL
.	NULL

and	NULL
Mathews.M.B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
4	NULL
.	NULL

2397-2408	NULL
.	NULL

Lazinski	NULL
,	NULL
D.	NULL
,	NULL
Grzadzielska	NULL
,	NULL
E	NULL
.	NULL

and	NULL
Das.A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Cell	NULL
,	NULL
59	NULL
,	NULL
207-218	NULL
.	NULL

Lechtenberg.R	NULL
.	NULL

and	NULL
Sher.J.H	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
AIDS	NULL
in	NULL
the	NULL
Nervous	NULL
System	NULL
,	NULL
Churchill	NULL
Livingstone	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Levy.J	NULL
.	NULL

A..	NULL
,	NULL
Shimabukuro.J..	NULL
Hollander	NULL
,	NULL
H.	NULL
,	NULL
MillsJ	NULL
.	NULL

and	NULL
Kaminsky.L	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
TAR-independent	NULL
transactivation	NULL
by	NULL
Tat	NULL
Lancet	NULL
,	NULL
2	NULL
,	NULL
586-588	NULL
.	NULL

Li	NULL
,	NULL
X.L	NULL
.	NULL

,	NULL
Moudgil	NULL
,	NULL
T.	NULL
,	NULL
Vinters	NULL
,	NULL
H.V	NULL
.	NULL

and	NULL
Ho	NULL
,	NULL
D.D	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
64	NULL
,	NULL
1383-1387	NULL
.	NULL

Luckow	NULL
,	NULL
B	NULL
.	NULL

and	NULL
Schultz	NULL
,	NULL
G	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
15	NULL
,	NULL
5490	NULL
.	NULL

Maniatis	NULL
,	NULL
T.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.F	NULL
.	NULL

and	NULL
Sambrook	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
a	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
.	NULL

McCune	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Rabin	NULL
,	NULL
L.B	NULL
.	NULL

,	NULL
Feinberg	NULL
,	NULL
M.B	NULL
.	NULL

,	NULL
Lieberman	NULL
,	NULL
M.	NULL
,	NULL
Kosek	NULL
,	NULL
J.C.	NULL
,	NULL
Reyes	NULL
,	NULL
G.R	NULL
.	NULL

and	NULL
Weissman	NULL
,	NULL
L.L	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cell	NULL
,	NULL
53	NULL
,	NULL
55-67	NULL
.	NULL

Michaels.J	NULL
.	NULL

,	NULL
Sharer	NULL
,	NULL
L.R	NULL
.	NULL

and	NULL
Epstein	NULL
,	NULL
L.G	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Immunodef	NULL
.	NULL

Rev	NULL
.	NULL

,	NULL
1	NULL
,	NULL
71-104	NULL
.	NULL

Muesing	NULL
.	NULL

,	NULL
M.A	NULL
.	NULL

,	NULL
Smith	NULL
,	NULL
D.H.	NULL
and	NULL
Capon	NULL
,	NULL
D.J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Cell	NULL
,	NULL
48	NULL
,	NULL
691-701	NULL
.	NULL

Muller	NULL
,	NULL
W.E	NULL
.	NULL

,	NULL
Okamoto.T	NULL
.	NULL

,	NULL
Reuter	NULL
,	NULL
P.	NULL
,	NULL
Ugarkovic	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Schroder	NULL
,	NULL
H.C	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
265	NULL
,	NULL
3803-3808	NULL
.	NULL

Nabel.G	NULL
.	NULL

and	NULL
Baitimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Nature	NULL
,	NULL
326	NULL
,	NULL
711-714	NULL
.	NULL

Navia	NULL
,	NULL
B.A	NULL
.	NULL

and	NULL
Price	NULL
,	NULL
R.W	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Arch	NULL
.	NULL

Neurol	NULL
.	NULL

,	NULL
44	NULL
,	NULL
65-69	NULL
.	NULL

Navia	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Cho	NULL
,	NULL
E.S	NULL
.	NULL

,	NULL
Petito	NULL
,	NULL
C.K	NULL
.	NULL

and	NULL
Price	NULL
,	NULL
R.W	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Ann	NULL
.	NULL

Neurol	NULL
.	NULL

,	NULL
19	NULL
,	NULL
525-535	NULL
.	NULL

Okamoto.T	NULL
.	NULL

,	NULL
Benter	NULL
,	NULL
T.	NULL
,	NULL
Josephs	NULL
,	NULL
S.F	NULL
.	NULL

,	NULL
Sadaie	NULL
,	NULL
M.R	NULL
.	NULL

and	NULL
Wong-Staal	NULL
,	NULL
F	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Virology	NULL
,	NULL
177	NULL
,	NULL
606-614	NULL
.	NULL

Pang	NULL
,	NULL
$	NULL
.	NULL

,	NULL
Koyanagi	NULL
,	NULL
Y.	NULL
,	NULL
Miles	NULL
,	NULL
S.	NULL
,	NULL
Wiley	NULL
,	NULL
C.	NULL
,	NULL
Vinters	NULL
,	NULL
H.V	NULL
.	NULL

and	NULL
Chen	NULL
,	NULL
L.S.Y	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Nature	NULL
,	NULL
343	NULL
,	NULL
85-89	NULL
.	NULL

Pomerantz	NULL
,	NULL
R.J.	NULL
,	NULL
Trono	NULL
,	NULL
D.	NULL
,	NULL
Feinberg	NULL
,	NULL
M.	NULL
B.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
,	NULL
61	NULL
,	NULL
1271-1276	NULL
.	NULL

Price	NULL
,	NULL
R.W	NULL
.	NULL

,	NULL
Brew	NULL
,	NULL
B.J	NULL
.	NULL

,	NULL
Sidtis	NULL
,	NULL
J.J.	NULL
,	NULL
Rosenblum	NULL
,	NULL
M.	NULL
,	NULL
Scheck	NULL
,	NULL
A.C	NULL
.	NULL

and	NULL
Cleary	NULL
,	NULL
P	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Science	NULL
,	NULL
239	NULL
,	NULL
586-592	NULL
.	NULL

Price	NULL
,	NULL
Brew	NULL
,	NULL
B.J	NULL
.	NULL

and	NULL
Rosenblum	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
In	NULL
Waksman	NULL
,	NULL
B.H	NULL
.	NULL

(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Immunologic	NULL
Mechanisms	NULL
in	NULL
Neurologic	NULL
and	NULL
Psychiatric	NULL
Disease	NULL
.	NULL

Raven	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
,	NULL
pp	NULL
.	NULL

269-289	NULL
.	NULL

Queen	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Cell	NULL
,	NULL
33	NULL
,	NULL
741-748	NULL
.	NULL

Ratnasabapathy	NULL
,	NULL
R.	NULL
,	NULL
Sheldon	NULL
,	NULL
M.	NULL
,	NULL
Johal	NULL
,	NULL
L	NULL
.	NULL

and	NULL
Hernandez	NULL
,	NULL
N.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
4	NULL
,	NULL
2061-2074	NULL
.	NULL

Reyes	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Weissman	NULL
,	NULL
L.L	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cell	NULL
,	NULL
53	NULL
,	NULL
55-67	NULL
.	NULL

Rhodes	NULL
,	NULL
R.H.	NULL
,	NULL
Ward	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Walker	NULL
,	NULL
D.L	NULL
.	NULL

and	NULL
Ross	NULL
,	NULL
A	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Arch	NULL
.	NULL

Pathol	NULL
.	NULL

Lab	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
112	NULL
,	NULL
1207-1213	NULL
.	NULL

Rosen	NULL
,	NULL
C.A	NULL
.	NULL

,	NULL
Sodroski	NULL
,	NULL
J.G	NULL
.	NULL

and	NULL
Haseltine	NULL
,	NULL
W.	NULL
A	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Cell	NULL
,	NULL
41	NULL
,	NULL
813-823	NULL
.	NULL

Rosenblum	NULL
,	NULL
M.L	NULL
.	NULL

,	NULL
Levy	NULL
,	NULL
R.M	NULL
.	NULL

and	NULL
Bredesen	NULL
,	NULL
D.E	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
AIDS	NULL
and	NULL
the	NULL
Nervous	NULL
system	NULL
.	NULL

Raven	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Roy	NULL
,	NULL
S.	NULL
,	NULL
Delling	NULL
,	NULL
U.	NULL
,	NULL
Chen	NULL
,	NULL
C.-H.	NULL
,	NULL
Rosen	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Sonenberg	NULL
,	NULL
N	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
4	NULL
,	NULL
1365-1373	NULL
.	NULL

Schmidt	NULL
.	NULL

A.	NULL
,	NULL
Hennighausen.L	NULL
.	NULL

and	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
64	NULL
,	NULL
4037-4041	NULL
.	NULL

Selby	NULL
,	NULL
M.J.	NULL
and	NULL
Peterlin	NULL
,	NULL
B.M	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
,	NULL
62	NULL
,	NULL
769-776	NULL
.	NULL

Singh	NULL
,	NULL
H.	NULL
,	NULL
Sen	NULL
,	NULL
R.	NULL
,	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Sharp	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Nature	NULL
,	NULL
319	NULL
,	NULL
154-158	NULL
.	NULL

Sodroski	NULL
,	NULL
J.	NULL
,	NULL
Patarca	NULL
,	NULL
R.	NULL
,	NULL
Rosen	NULL
,	NULL
C.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F	NULL
.	NULL

and	NULL
Haseltine	NULL
,	NULL
W.A	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Science	NULL
,	NULL
229	NULL
,	NULL
74-77	NULL
.	NULL

Southgate	NULL
,	NULL
C.D	NULL
.	NULL

and	NULL
Green	NULL
,	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
5	NULL
,	NULL
2496-2507	NULL
.	NULL

Southgate	NULL
,	NULL
C.	NULL
,	NULL
Zapp.M.L	NULL
.	NULL

and	NULL
Green	NULL
,	NULL
M.R	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Nature	NULL
,	NULL
345	NULL
,	NULL
640-642	NULL
.	NULL

Tornatore	NULL
,	NULL
C.	NULL
,	NULL
Nath	NULL
,	NULL
A.	NULL
,	NULL
Amemiya	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Major	NULL
,	NULL
E.O	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
65	NULL
,	NULL
6094-6100	NULL
.	NULL

Ward	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
O'leary	NULL
,	NULL
T.J.	NULL
,	NULL
Baskin	NULL
,	NULL
G.B	NULL
.	NULL

,	NULL
Beneviste.R	NULL
.	NULL

,	NULL
Harris	NULL
,	NULL
C.A	NULL
.	NULL

,	NULL
Nara	NULL
,	NULL
P.L	NULL
.	NULL

and	NULL
Rhodes	NULL
,	NULL
R.H	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Am	NULL
.	NULL

J	NULL
.	NULL

Pathol	NULL
.	NULL

,	NULL
127	NULL
,	NULL
199-205	NULL
.	NULL

Wiley	NULL
,	NULL
C	NULL
.	NULL

A.	NULL
,	NULL
Schrier	NULL
,	NULL
R.D	NULL
.	NULL

,	NULL
Nelson	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
Lampert	NULL
,	NULL
P.W	NULL
.	NULL

and	NULL
Oldstone	NULL
,	NULL
M.B.A.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
83	NULL
,	NULL
7089-7093	NULL
.	NULL

Received	NULL
on	NULL
March	NULL
5	NULL
,	NULL
1992	NULL
;	NULL
revised	NULL
on	NULL
May	NULL
20	NULL
,	NULL
1992	NULL
3403	NULL

